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Abstract
The Gram-negative bacterium Bartonella henselae (Bh) is an emerging zoonotic
pathogen that has been associated with a variety of human diseases including bacillary
angiomatosis which is characterized by vasoproliferative tumor-like lesions on the skin
and internal organs of some immunosuppressed individuals. Several virulence factors
associated with Bartonella-induced pathogenesis have been characterized. However,
the study of those virulence factors has been limited to in vitro cell culture systems due
to the lack of a practical animal model. Therefore, we wanted to investigate whether the
zebrafish embryo (Danio rerio) could be used to model human infection with Bh. We
investigated if Bh can mount an infection in zebrafish embryos during their early stage
of development. Our data showed that Tg(fli1:egfp)y1 zebrafish embryos supported a
sustained Bh infection for 7 days with >10-fold bacterial replication when inoculated in
the yolk sac. This was evident by plating of zebrafish homogenates, quantitative PCR,
and confocal microscopy analysis. We assessed the interaction of Bh with EC and the
phagocytic cells in live embryos by microscopy. Our data showed that aggregates of Bh
interact with the endothelium of the embryo vasculature. Evidence showed that Bh
recruited phagocytes to the site of infection in the Tg(mpx:GFP)uwm1 embryos. We
also wanted to determine the response to infection with Bh. Infected embryos showed
evidence of a Bh-induced angiogenic phenotype as well as an increase in expression of
genes encoding pro-inflammatory factors and pro-angiogenic markers. A deletion
mutant for the entire VirB type IV secretion system (ΔvirB2-11) supported bacterial

vii

replication although to a lesser degree compared to the wild type control. However,
infection of zebrafish embryos with a deletion mutant in the major adhesin (BadA)
resulted in little or no bacterial replication and a diminished pro-angiogenic and proinflammatory host response compared to wild type Bh, providing the first evidence that
BadA is critical for in vivo infection. Thus, the zebrafish embryo provides the first
practical animal model of Bh infection that will facilitate efforts to identify virulence
factors and define molecular mechanisms of Bh pathogenesis.
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Chapter 1
Introduction
1.1. Bartonella species, their hosts and human diseases
Bartonella are small, pleomorphic Gram-negative rod-shaped bacteria which
belong to the α2 subgroup of the class Proteobacteria [4]. Bartonella formerly known as
Rochalimaea are closely related to the genera Brucella and Agrobacterium [5]. To date,
over 30 species or subspecies of Bartonella have been identified and classified using
molecular methods such as PCR using specific primers to Bartonella 16S ribosomal
DNA and the tmRNA gene (ssrA) [5,6]. As the development of new molecular methods
improves, it is expected that the number of identified Bartonella species will increase.
The genus Bartonella includes fastidious, facultative intracellular bacteria that are
associated with endothelial cells (EC) and erythrocytes of a variety of hosts including
rabbit, cat, rodent and human (Table 1.1) [3,7-9]. All of the identified Bartonella species
have been associated with mammalian hosts and at least 12 of them are identified as
human pathogens. B. bacilliformis and B. quintana have been isolated from humans
[10,11]. Bartonella vinsonii subsp. berkhoffii has been isolated from dogs [12]. B.
henselae, B. clarridgeiae and B. koehlerae have been found in cats [13-15]. B. doshiae,
B. grahamii, and B. vinsonii subspecies vinsonii have been isolated from voles [5,16]. B.
elizabethae, B. taylorii, B. birtlesii and B. tribocorum have been recovered from rats
[5,16-18]. B. vinsonii subsp. arupensis was isolated from mice [19].

1

Table 1.1. List of Bartonella species (subspecies), their natural hosts,
vectors, and human diseases. Over 30 species and subspecies of Bartonella
have been identified worldwide. More than 25 of those species have been
associated with mammalian hosts and at least 12 of them are identified as human
pathogens causing a wide array of diseases in human. Table reproduced From
Vayssier-Taussat et al. 2009 with authors’ permission [3].
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Bartonella are emerging pathogens that are involved in a number of disease
manifestations in humans and animals. Infections caused by this group of bacteria
range from chronic bacteremia with no apparent symptoms in their reservoir hosts to
self-limiting regional lymphadenitis and more complicated endocarditis in the human
host [20-22]. Although mammals seem to be an important reservoir host for Bartonella,
most of the human diseases are caused by only three species: B. bacilliformis, B.
quintana and Bh.
Humans are the only known reservoir for B. bacilliformis, the bacterial agent of
the biphasic disease bartonellosis (Carrion’s disease). The bacteria are transmitted
between humans through bites of infected female sand flies Lutzomyia verrucarum
[23,24]. Once the bacteria enter the human blood, they colonize almost all of the
erythrocytes leading to an acute and severe hemolytic anemia causing a wide array of
symptoms including myalgia, fever and headache; this phase is known as oroya fever
[25,26]. The second phase of the disease is verruga peruana, which may be sequential
or independent of Oroya fever, and is characterized by non-fatal tumor-like lesions seen
mainly on the skin [27-29]. An outbreak of bartonellosis resulting in more than 7000
deaths was reported in 1871 in the high-altitude valleys and remote areas of South
American Andes [30,31]. Mortality during the acute phase of bartonellosis ranged from 1
percent in the case of patients receiving antibiotic treatment to 88 percent in the
untreated although some of the mortality might be attributed to secondary infection with
bacteria and viruses [10,30,32].
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Like B. bacilliformis, humans are the primary reservoir for B. quintana. The
pathogen is transmitted between humans by the body louse (Pediculus humanus
corporis) and historically known to cause trench fever, characterized by a recurrent and
cycling (every 5-day) fever in the human host [33]. Approximately 1 million people in
Europe were affected by trench fever during World War I [34]. Although the incidence of
trench fever has substantially declined since World War I, the condition has reemerged
as urban trench fever among the poverty-stricken, alcoholic and homeless individuals
living in poor health and hygienic conditions [35]. Moreover, for the past two decades, B.
quintana have been associated with other infections namely endocarditis, chronic
bacteremia primarily among the poor and bacillary angiomatosis in immunosuppressed
individuals [36-39].
While humans are the reservoir hosts for B. bacilliformis and B. quintana, cats
are the natural host for Bh in which the bacteria cause an asymptomatic
intraerythrocytic infection [14,40]. The organism, however, can be transmitted between
cats through cat fleas (Ctenocephalides felis), and from infected cats to humans by
bites and scratches (Fig. 1.1) [41,42]. Although infected cats show an asymptomatic
bacteremia, this zoonotic pathogen can cause a wide array of infections in the human
incidental host. Immunocompetent patients infected with Bh typically suffer from cat
scratch disease (CSD) which is a benign subcutaneous lymphadenopathy associated
with fever [43,44]. It is estimated that 22,000 – 24,000 cases of CSD are diagnosed
yearly, mainly in children, in the United States [45,46]. Although CSD is considered to
be a self-limiting infection, over 10% of those cases require hospitalization and if not
treated the bacteria can disseminate to other organs such as the liver, the brain and the
4

heart leading to more serious complications [12,45]. Immunosuppressed individuals
such as HIV patients infected with Bh can develop a more systemic infection
characterized by vasoproliferative tumor-like lesions called bacillary angiomatosis (BA)
and bacillary peliosis (BP) on the skin and liver, respectively [47]. According to the CDC,
the exact incidence of BA and BP is not known; however, cases have been reported in
all 50 states in the U.S., with the majority in men because of the disproportionate
incidence of HIV in men.

Figure 1.1. Bh infection in cat and the human incidental host. Bh causes
intra-erythrocytic bacteremia in cats. Infection is spread between cats through the
cat flea vector. The pathogen is transmitted to the human incidental host by
scratches or cat bites from an infected cat. Immunocompetent individuals
develop cat scratch disease and immunosuppressed individuals develop bacillary
angiomatosis. Figure copied from Dehio, 2005 with author’s permission [2].
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1.2. Bh pathogenesis and infection strategy
Upon inoculation of a mammalian host, Bartonella are believed to reside in what
researchers call a “primary niche”, outside of the bloodstream partly to avoid elicitation
of a host immune response as the bacteria are not capable of directly invading the
erythrocytes until the host or the bacteria are primed to do so [48]. The nature of this
primary niche in Bartonella infection has not been completely established yet. This is
perhaps, in part because infection strategy and host-pathogen specificity differ among
species, and in part because of the lack of a suitable animal model. Although the
cellular composition of the primary niche is not completely clear, in vitro data suggest
that it may involve EC, migratory cells such as lymphocytes and mononuclear
phagocytes which may play a role in the transport of the bacteria into the microvascular
environment [2,20].
Bh is thought to be transmitted to the human incidental host mainly indirectly
through cat flea feces via cat scratches or cat bites [49]. Once the bacteria are
inoculated, they can invade many cell types including EC [50], hematopoietic progenitor
cells [51], epithelial cells [8], monocytes and macrophages [52,53]. It has been shown
that Bh entry into EC can happen by two alternative routes: single bacteria uptake via a
zipper-like mechanism or as large bacterial aggregates in a structure called the
“invasome” [54,55]. Bacteria-containing vacuoles accumulate in the perinuclear space
where they fail to acidify and fuse with the lysosome [48]. Consequently, the bacteria
are able to replicate and persist in the host cells. Bh was shown to induce the secretion
of IL-10 in both in vitro and in vivo studies [56,57]. Secretion of IL10, a potent antiinflammatory cytokine which suppresses the function of immune cells including
6

macrophages and dendritic cells, may contribute to an asymptomatic and persistent
course of infection favoring Bh [48].

Cat scratch Disease
CSD is the most commonly known disease manifestation associated with Bh
infection in immunocompetent individuals. As reviewed by Florin et al., CSD begins after
3 to 10 days with an erythematous papule at the site of inoculation with Bh, then the
lesions progress through vesicular and papular crusted stages, and persist for 1 to 3
weeks [21]. The swelling of the lymph nodes results from granuloma formation via
recruitment and stimulation of macrophages during an interferon gamma (INF-γ)mediated T helper 1 cell response [53]. Moreover, electron microscopy of lymph node
tissues of patients with CSD show the presence of Bh near the vascular endothelium,
with organisms seen in clumps in vessel walls [58].

Bh-induced angiogenesis
One of the most captivating features of infection with Bh is its ability to cause
angioproliferative lesions. The pathological lesions seen in BA patients resemble those
of Kaposi’s sarcoma associated with human herpes virus 8 infection [59]. Histological
studies revealed the presence of immature capillaries that are lined with swollen
endothelium in BA lesions, and the lesions are packed with bacterial aggregates and
infiltrated by macrophages and neutrophils [60,61]. It is believed that live Bh actively
trigger the vasoproliferative activity since the observed EC proliferation completely
regresses after treatment with antibiotic [21]. As in tumor angiogenesis, Bartonella7

triggered neovascularization follows a series of steps that involve disruption of the
normal pattern of the extracellular matrix and basal membrane, endothelial cell
migration and proliferation at the site of angiogenic stimuli [62]. Kirby developed an in
vitro model of Bh-induced angiogenesis and showed that in addition to endothelial
proliferation, Bh coordinated a series of events which included matrix invasion, survival
of type I collagen and endothelial tubular differentiation [63].
The molecular basis of Bh-induced angiogenesis has been extensively studied in
cell culture models. Our current understanding suggests that the process involves at
least three mechanisms that work synergistically: 1) mitogenic triggering of endothelial
cell proliferation, 2) inhibition of apoptosis (contact-dependent or independent), and 3)
angiogenic reprogramming of infected host cells (with pro-inflammatory activation of
cytokines) [64]. Both live and cell extracts of Bh are capable of inducing the proliferation
and migration of HUVEC [65,66]. For instance, GroEL, a heat shock protein, was shown
to be secreted in Bh extracts and caused endothelial cell proliferation by triggering the
release of intracellular calcium [67,68]. EC proliferation was also shown to be
dependent on anti-apoptotic activity as Bh inhibits the apoptosis of HUVEC by inhibiting
the activities of caspase 3 and caspase 8 [69]. Bh infection of EC triggers an NF-kBdependent release of ICAM-1, E-selectin, MCP-1, and IL-8, some of which may exert a
direct effect on EC in an autocrine manner leading to cell proliferation, but also may
recruit monocytes/macrophages and polymorphonuclear cells to the sites of infection
[1,70-72]. As demonstrated by Resto-Ruiz, the interaction of Bh with the human
macrophage cell line THP-1 triggered the release of vascular endothelial growth factor
(VEGF), a potent stimulator of angiogenesis, as well as IL-1β [1]. VEGF acted on EC
8

leading to further cell proliferation and ultimately angiogenesis constituting the paracrine
angiogenic loop (Fig. 1.2).

Figure 1.2. Paracrine loop model of Bh-induced angiogenesis. Upon adherence
to and invasion of macrophages (mac) and neutrophils via BadA, B. henselae
induced the production of VEGF which functions in a paracrine manner and acts as a
mitogen to endothelial cells (EC) leading to cell proliferation and angiogenesis. When
EC are infected with B. henselae through the VirB T4SS and the expression of the
Bartonella effector proteins (Beps), a cascade of pathways occurs leading to
production of pro-angiogenic chemokines and cytokines, which may exert a direct
effect on the EC or may recruit monocytes and neutrophils to site of inflammation
leading to further EC proliferation and angiogenesis. Figure is adapted from RestoRuiz et al. with author’s permission [1].

1.3. Bh virulence factors
For the past decade, Bartonella research has been advancing at a fast pace due
in part to the availability of the complete genome sequence for Bh and the appropriate
cell culture models [73]. This has enabled the establishment of gene function and
definition of important virulence factors including secreted factors as well as membranebound proteins associated with Bh-induced pathogenesis for further in vitro studies.
9

Bartonella adhesin A
Bartonella adhesin A (BadA) belongs to the class of trimeric autotransporter
adhesins along with YadA from Yersinia enterocolitica and NadA from Neisseria
meningitidis. These proteins represents important virulence factors of Gram-negative
bacteria in the form of an extracellular filament consisting of a head, neck and repetitive
stalk domains assembled on a C-terminal membrane anchor domain [74,75]. There are
at least two variants of the badA gene with the best-characterized one, badA full-length
(BH01510), encoding a large protein made up of more than 3000 amino acids resulting
in a size of 328 kDa per polypeptide chain and a length of 240 nm [64]. In vitro studies
of Bh infection have shown that BadA is critical for adhesion to host cells and
extracellular matrix proteins such as fibronectin and collagens, as well as inhibition of
phagocytosis and induction of angiogenesis [76]. The expression of BadA has been
shown to correlate with a pro-angiogenic cell response via activation of hypoxiainducible factor 1-alpha (HIF 1-α) and the subsequent secretion of the pro-angiogenic
factor VEGF [52,76-78].

VirB/VirD4 type 4 secretion system
Many pathogenic bacteria utilize a type IV secretion system (T4SS) to
translocate DNA and effector molecules into the host cells to influence cellular
functions. The VirB/VirD4 system of the plant tumor-inducing plasmid pTiC58 of
Agrobacterium tumefaciens is the best-characterized member of this transporter family
and consists of 10 essential components: VirB2-11 plus the type IV secretion substrate
10

recognition module VirD4 [79]. The T4SS consists of a translocation channel that spans
both the inner and outer membrane of Gram-negative bacteria and merges into a
surface filament mediating the initial attachment to the target cells [80]. The VirB/VirD4
T4SS has also been well-characterized in Bh and shown to transfer important
Bartonella effector proteins (BepA through BepG) to host cells where they disrupt
cellular functions favoring survival of the bacteria [81,82]. In vitro studies of human
endothelial cells cultured with Bh showed that VirB/VirD4 T4SS along with the Beps
mediate cellular changes such as a massive cytoskeletal rearrangement leading to the
uptake of bacterial aggregates by a structure termed the “invasome” [54]. In addition,
the VirB/VirD4 T4SS is required for NF-kB-dependent pro-inflammatory cytokine
activation of IL-8 [83], expression of the cell adhesion molecules ((ICAM)-1 and Eselectin) [71], and inhibition of endothelial cell apoptosis [80,83]. Recently, the role of
some of the Beps was investigated by Scheidegger et al. using a 3D in vitro
angiogenesis assay of collagen gel-embedded EC spheroids [84]. BepC, BepF and
BepG were shown to promote invasome-mediated uptake of large Bh aggregates [84].
While BepG by itself was shown to exhibit an anti-angiogenic activity interfering with
sprout formation, BepA was shown to induce sprouting of the endothelial spheroids
similarly to sprouting triggered by VEGF [84].

Trw type 4 secretion system
The Trw T4SS is the other and the less studied T4SS found in Bartonella. The
VirB T4SS is required for the early infection stage and involved in establishing
interaction of Bh with EC and in translocating effector proteins into the host cells [79,81],
11

whereas the Trw T4SS is involved in adherence and invasion of erythrocytes by
surface-expressed T4SS pili and has not been shown to have the ability to transfer
effectors into the host erythrocytes [82]. It has been suggested that the loss of flagella is
correlated with the acquisition of Trw T4SS by the modern lineage species such as Bh,
and the Trw system fulfills the erythrocyte adhesion role of the flagella among nonflagellated Bartonella spp. [82]. The trw locus has multiple tandem gene duplications of
trwL and trwJ-trwH which encode small adhesin-like proteins with varying copy numbers
among Bartonella species [85]. The TrwJ and TrwL are the surface-exposed
components that have been shown to specifically adhere to erythrocytes with TrwJ1 and
TrwJ2 conferring host specificity for the bacteria [85-87].

Lipopolysaccharide (LPS)
LPS is a major component of the outer membrane of Gram-negative bacteria,
and plays an important role in the pathogenicity of the bacteria. LPS induces a signaling
cascade that leads to a NF-kB-dependent inflammatory response by binding to
TLR4/TLR2, which interacts with accessory proteins CD14 and myeloid differentiation 2
[88]. A pronounced immune response to LPS can lead to septic shock [89]. LPS of
Bartonella has been shown to exhibit very low endotoxic activity, and this has been
speculated to result in remarkable interaction and persistence of Bh in the endotoxinsensitive EC causing an angioproliferative phenotype rather than sepsis [90]. Bh LPS is
structurally different than the typical LPS from E. coli [91], and evidence shows that
purified Bh LPS did not stimulate TLR2 [92]. As reviewed by Harms and Dehio,
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Bartonella LPS may have an immunomodulatory effect by acting antagonistically on
TLR4 [48].

Other virulence factors
Outer membrane proteins (OMPs) (28, 32, 43, 52, and 58 kDa) were described in
Bh and shown to adhere to EC in vitro [93]. OMP43 was shown to bind fibronectin and
human umbilical vein endothelial cells and might play a very important role in Bartonella
infection [94,95]. It was demonstrated that Bh OMPs were sufficient to induce NFkB activation and expression of adhesion molecule followed by enhanced rolling
and adhesion of leukocytes [71].

1.4. Previous Bartonella infection models
For over a decade, researchers have been looking into developing an animal
model to study Bartonella infection and host response, but the efforts to establish such
a model have met with limited success. Cats, the natural reservoir of Bh, when infected,
do not exhibit symptoms such as lymphadenopathy and vasculoproliferation as seen in
infected humans [96]. A primate rhesus macaque (Macaca mulatta) model was shown
to reproduce characteristics of human infection with B. quintana [97], but use of this
model system for Bh has not been reported. Moreover, attempts were made to infect
C57BL/6 as well as BALB/c mice by inoculating 107 to 108 Bh cfu intraperitoneally or
subcutaneously. However, both strains of mice were shown to clear the bacteria within
days of inoculation with no increase in bacterial burden [98,99]. The mechanism by
which the bacteria were cleared was not fully investigated. For those underlying
13

reasons, this research project aimed at investigating whether the zebrafish (Danio rerio)
embryo model could be used to study Bh pathogenesis and response to infection.

1.5. The zebrafish embryo model
Overview
Many invertebrate models including fruit fly (Drosophila) and the nematode
worm, Caenorhabditis elegans, have been instrumental in helping investigate
fundamental concepts in genetics and early development. Historically, mice have been
the model of choice for developmental and genetic studies of vertebrates. However,
there are several drawbacks: because fruit fly and C. elegans are invertebrates, they
are evolutionarily divergent from humans and many key organs and the sophisticated
immune system are absent in C. elegans [100]. Although mice are more closely related
to humans, it is difficult to directly observe the cellular development because
embryogenesis occurs in the uterus. In the early 1970’s, Dr. Georges Streisinger, a
researcher at the University of Oregon, identified and developed the zebrafish as a
model for genetic and developmental studies of vertebrates [101]. Since then the
zebrafish has become a very popular model and used as a means to understand not
only genetics and development of other fish but also as a means to study development
in higher vertebrates.
For decades the zebrafish embryo model has been an invaluable tool for genetic
and developmental studies [102,103], but recently the use of zebrafish embryos has
been extended to model pathogenesis in humans including bacterial infection and tumor
angiogenesis, and to study drug discovery. The zebrafish embryo model has been used
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to study infections with a number of Gram-positive as well as Gram-negative bacteria.
For instance, zebrafish are susceptible to Streptococcus pyogenes, Pseudomonas
aeruginosa,

Staphylococcus

aureus

and

Salmonella

typhimurium

[104-107].

Angiogenesis-inducing factor FGF-2 and mammalian tumor xenografts have been
shown to induce neovascularization in the zebrafish embryo model [108-110]. More
recently, the zebrafish embryo model has been applied to large scale drug screening
and to detect off-target effects of drug candidates [111-113].
The zebrafish embryo model has increasingly attracted researchers for its utility
in studying human diseases. Adult zebrafish reach sexual maturity at 3 to 4 months and
a female can lay an average of 200 eggs a week for up to 4 years [114]. Zebrafish
embryos are translucent during the first weeks post-fertilization making them suitable for
microscopy allowing real-time analysis of bacterial infection [107]. Their ex-utero
development allows access to embryos at all stages of development making postfertilization genetic manipulation of zebrafish embryos much easier. However, one of
the most important characteristics is that they share similarities with the human immune
system, having both innate and adaptive immune systems featuring the myeloid and
lymphoid cells such as macrophages, neutrophils, dendritic cells, T cells and B cells
[115-117].

1.6. Zebrafish innate immune system
The innate immune system, which is composed of physical barriers, cellular and
humoral components, is the first line of defense against infection. In the zebrafish
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embryo, antimicrobial peptides, complement components and phagocytes are present
within 24 hours post-fertilization (hpf) [115,116,118].

Cellular development and maturation
In the zebrafish, hematopoiesis begins as early as 5 hpf producing three germ
layers: ectoderm, mesoderm and endoderm [119]. Immune cell development occurs in
waves of primitive and definitive hematopoiesis [120,121]. The primitive hematopoiesis
starts in the anterior lateral plate, in which hemangioblasts differentiate into myeloid
cells, and in the posterior lateral plate mesoderm which gives rise to erythrocytes [122].
The posterior lateral plate later develops and expands into the caudal hematopoietic
tissue, a transitory site for erythroid and myeloid progenitor cells, from where they
migrate to reside in the thymus and the pronephros, the definitive hematopoietic organs
[122-124]. The pronephros develos into kidney marrow, which is the equivalent to bone
marrow in humans [115]. The final wave of definitive hematopoiesis occurs in the
ventral wall of the dorsal aorta in which cells that have the ability to reconstitute all of
the hematopoietic lineages are produced [125,126].
Macrophages are the first leukocytes in the zebrafish embryo to differentiate
[127]. The ontogeny and behavior of early macrophages were studied by Herbomel et
al. using video enhanced differential interference contrast (DIC) microscopy and in-situ
hybridization for hematopoietic marker genes draculin and leukocytes-specific plastin
[118]. As reported by Herbomel et al., macrophages migrate into the yolk sac as
precursors cells where they differentiate just before the onset of blood circulation; many
subsequently enter the blood circulation while others invade the mesenchyme of the
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head, retina and epidermis [118]. At 30 hpf, macrophages are seen phagocytizing large
amounts of bacteria soon after intravenous injection, and they can sense microbes
injected though body cavities leading to their migration and killing of the microorganisms
[118]. Although myeloperoxidase (mpx), a molecular marker for neutrophils, mRNA is
detected as early as 28 hpf, the presence of mature neutrophils is not documented until
48 hpf where they are seen in the trunk and tail of the zebrafish embryo [128-130].
Other myeloid cells that have been described in the zebrafish include mast cells,
eosinophils and a population of dendritic-like antigen-presenting cells [117,131,132].

Transgenic reporter lines for live imaging
Transgenic reporter lines expressing fluorescent proteins driven by leukocytespecific promoters are available to study the behavior of immune cells using live
imaging. This technology helps in studying host-pathogen interactions in the zebrafish
embryo model. Precursors of myeloid cells can be visualized using the spi1- or pu.-1
GFP transgenic lines [130,133,134]. In addition to being used for vasculature system
visualization, the Tg(fli1:EGFP)y1 transgenic line has been used to visualize early
myeloid cells [135]. The mpx or mpo promoter is used in two transgenic lines to label
neutrophil populations with bright GFP and an additional population of low GFPexpressing inflammatory macrophages [136,137]. A macrophage-specific line has also
been created using the promoter sequence of the mpeg1 gene [138].
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Pattern recognition receptors
Like mammals and higher vertebrates, the zebrafish embryo expresses a broad
range of germline-encoded pattern recognition receptors (PRRs) and adaptors. Those
receptors are found on the surface, the endosomal compartments and in the cytosol of
leukocytes including dendritic cells and macrophages recognizing evolutionarily
conserved markers on pathogens called pathogen-associated molecular pattern
(PAMPs) [139]. Some of the PAMPs expressed by zebrafish embryos include Toll-like
receptors (TLRs) [140], NOD-like receptors (NLRs) [64,141], and C-type lectin receptors
such as the complement activating mannose binding lectin (MBL) [142]. Upon the
recognition of a PAMP, PRRs send signals to initiate pro-inflammatory and antimicrobial
responses through different signaling cascades leading to production of proinflammatory cytokines, chemokines and antimicrobial peptides [143].

Toll-like receptors
TLRs are type I transmembrane proteins defined by the presence of an
extracellular domain containing leucine-rich repeats (LRRs) and a cytoplasmic tail that
contains a conserved region called the Toll/IL-1 receptor (TIR) domain that binds
adaptor proteins such as MYD88, Mal, TICAM-1, TRAM or SARM at the TIR domain to
initiate signal transduction [144-148]. Following interaction with PAMPs, TLRs relay
signals from the cell surface to the nucleus through adaptor molecules which share a
common Toll/interleukine-1 receptor (TIR) domain with TLRs [116,145]. This process
leads to MAP kinases family members’ activation, NF-kB translocation to the nucleus
and ultimately the activation of inflammatory cytokines and chemokines, antimicrobial
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mechanisms involving production of reactive oxygen and nitrogen species, and the
triggering of the adaptive immune response [149].
The TLR family was first described in Drosophila and was shown to be implicated
not only in immune defense but also in development [150,151]. In mammals and
vertebrates, however, they are mainly involved in the innate immune system [152,153].
In the zebrafish, TLRs start to express shortly after gastrulation and over 22 putative
variants of TLRs including orthologs of the human TLR families have been
characterized [154,155]. In humans, TLR4 recognizes lipopolysaccharide (LPS) on the
outer membrane of Gram-negative bacteria, TLR1 and TLR3 recognize lipoprotein and
peptidoglycan from Gram-positive bacteria, TLR5 binds to bacterial flagella, and TLRs
3, 7, 8, and 9 recognize viral nucleic acid during viral infection [156]. Most zebrafish
TLRs share the same functionality with human TLRs, but because of genome
duplication and alternative splicing zebrafish often have two forms of the TLRs [154].
For instance, zebrafish has two paralogs of TLR4 (TLR4a and TLR4b). However, as
opposed to human, it was shown that LPS signaled through a TLR4- and MyD88independent manner in zebrafish, and that zebrafish TLR4a and TLR4b suppressed the
MyD88-dependent NF-κB activation by sequestering the TLR adaptors [157,158].

Other pattern recognition receptors
Other notable receptors described in the zebrafish antimicrobial immunity include
nucleotide-binding-oligomerization-domain-(NOD-) like receptors (NLRs), RIG-I-like
receptors (RLRs), scavenger receptors and C-type lectin receptors (CLRs). NLRs and
RLRs are cytosolic PRRs that recognize intracellular pathogens that escape the
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surveillance of the transmembrane PRRs [159]. Members of the NLR family (NOD1,
NOD2) can recognize molecules on parasites and can detect the presence of bacteria
through molecules produced during peptidoglycan synthesis or breakdown [160,161].
Though the function of NLR family members has not been broadly studied in the
zebrafish, typical members of the mammalian NLRs are conserved and play an
antimicrobial role in zebrafish embryos [162,163]. Members of the RLRs family
recognize viral RNA and when activated lead to production of type I interferon which
binds to its receptor to initiate expression of IFN-stimulated genes [163]. Zebrafish
homologs of some RLRs have been identified; however, analysis of their putative
proteins showed that their domains distribution differed from those of human [163,164].
Scavenger receptors are, on the other hand, cell surface family receptors that
are not only present on immune cells namely macrophages, mast cells and dendritic
cells, but they are also expressed by certain types of epithelial cells and endothelial
cells [165,166]. They bind to a wide range of PAMPs which include LTA, LPS and CpG
DNA [167]. Several homologs of the mammalian scavenger receptor family have been
identified in the zebrafish genome; however, their functional identity remains elusive.
For instance, the zebrafish macrophage receptor with collagenous structure (MARCO)
gene, a specific marker for macrophages and dendritic cells, has been shown to play
the same role in mammals as in zebrafish [167]. CLRs are soluble or membraneattached carbohydrate-binding proteins expressed by most cell types including
macrophages and dendritic cells [168,169]. The mannose binding lectin (MBL) is a CLR
protein that binds a wide array of sugar moieties found on fungi, protozoa, viruses and
bacteria and activates the complement system [170]. MBL has also been identified in
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zebrafish and was shown to be associated with complement activation and resistance to
bacterial infection [171].

Secreted proteins and peptide mediators of the innate immunity
Zebrafish embryos express a variety of secreted proteins and peptide mediators
such as cytokines, chemokines and antimicrobial peptides that not only control the
innate immune system but also play an important role in the activation of the adaptive
immune system in adult zebrafish. Homologs for many mammalian secreted proteins
and peptide mediators of the innate immune response have been identified in the
zebrafish embryo.

Cytokines
Cytokines are small proteins secreted by a broad range of nucleated cells
including macrophages, neutrophils, B and T lymphocytes and endothelial cells, and
have both autocrine and paracrine activities. The primary role of cytokines is to
modulate the amplitude and direction of the immune responses [172]. There are two
main groups of cytokines in inflammation: the pro-inflammatory cytokines which
promote inflammatory responses and the anti-inflammatory cytokines which are
involved in negative regulation of the inflammatory responses. The main proinflammatory cytokines produced by zebrafish phagocytes include tumor necrosis factor
(TNF), IL-1, IL-6, type I and type II IFNs, IL-22 and IL-26 [173-176]. In human, IL-10 is a
strong anti-inflammatory cytokine and acts antagonistically to pro-inflammatory cytokine
production by macrophage and T cells [177]. Zebrafish homologs IL-10 and its receptor,
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IL-10R1, are identified and characterized, and are believed to play a similar role in the
zebrafish immune response [178].
The importance of TNF signaling was studied in the zebrafish embryo infection
model of the facultative intracellular bacterium Mycobacterium marinum. It was shown
that TNF played a key role in controlling granuloma formation by inhibiting
mycobacterial growth within macrophages and restricting their necrotic death [179].
mRNA expression levels of tnf and il1b genes were shown to increase in zebrafish
embryos exposed to Edwardsiella tarda by static immersion as well as in adult zebrafish
by injection [173]. Both pro-and anti-inflammatory cytokines were shown to be
upregulated in zebrafish embryos in response to infection with Pseudomonas
aeruginosa and Salmonella typhimurium [105,180]. The zebrafish homologs of the
human IFNγ, IFN-γ1 and IFN-γ2, are required for resistance to bacterial infection in
zebrafish embryos. The interferons were shown to be necessary to clear E. coli infection
as well as Yersinia ruckeri, a natural fish pathogen that is lethal to the zebrafish
embryos at low dose [181]. IFNθ and IFNθ2 are two groups of interferons in zebrafish
that are closely related to human IFNs type I and type III, and shown to provide antiviral
protection in a viral challenge assay [182,183].

Chemokines
Chemokines are specialized cytokines that direct the migration of cells involved
in processes such as embryonic gastrulation and organogenesis, leukocyte trafficking,
and immune surveillance [184]. Because of those important biological roles,
chemokines have been viewed as key players in diseases involving infection,
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inflammation and tumor [185]. Interleukin-8 (IL-8) or CXCL8 is the prototypical member
of the CXC chemokines. This potent pro-inflammatory chemokine signals through
CXCL1 and CXCL2, two G-protein coupled receptors that are known to bind
chemokines other than IL-8 [186]. In addition to its chemotactic activity for neutrophils,
basophils and monocytes, CXCL8 regulates the growth of endothelial cells by
stimulating VEGF expression in an NF-kB-dependent manner [187]. Macrophagederived IL-8 signaling through CXCL2 has been shown to play a role in angiogenicdependent disorders such as tumor growth, rheumatoid arthritis, and wound healing
[188].
Zebrafish homologs of CXCL8 and its receptors have been sequenced and
characterized, and their signaling pathway was shown to be conserved in the zebrafish
embryo [185]. However, as opposed to its mammalian counterpart, zebrafish CXCL8
lacks the angiogenic ELR (Glu-Leu-Arg) motif that is known to play an important role in
the recruitment of neutrophils in humans [189,190]. Nevertheless, the expression of
zebrafish embryo IL-8 was shown to be upregulated in inflammatory conditions induced
by bacterial or chemical stimuli and was shown to be crucial for normal neutrophil
recruitment to the wound and normal resolution of inflammation [185,191].

Complement components
The complement system is an essential humoral system of innate immunity and
links the innate immune response to the adaptive immune response. This system
consists of over 35 secreted and membrane-bound proteins alerting the host of the
presence of pathogens and killing those pathogens [192,193]. The complement system
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can be activated through three different pathways: the classical pathway which is
initiated by the binding of the C1 complex to antibodies bound to structures on the
surface of the pathogen, the alternative pathway which is activated by the recognition of
certain structures on the surface of the microbe in an antibody-independent manner; the
lectin pathway which is triggered by the binding of polysaccharides to circulating lectins,
such as mannose-binding lectin [194]. These pathways merge into a common
amplification step involving C3, and continuing to the cytolytic pathway forming the
membrane attack complex (MAC), which lyses the cell membrane and kills the microbes
[195].
Zebrafish homologs of the fundamental complement components including C3,
MBL, factor B (Fb) and factor H (Fh) have been identified [142,196-198]. The mRNA
levels of c3 and bf in zebrafish embryo were shown to be significantly increased in
response to LPS exposure [199]. This was further supported by evidence showing that
cytosol prepared from newly fertilized eggs was able to kill E. coli [195]. The
antibacterial activity of zebrafish egg cytosol was also attributed to the presence of
lysozyme [200]. Moreover, many zebrafish complement components could be
transferred from mother to eggs as evidence showed that immunization of adult female
zebrafish with Aeromonas hydrophila resulted in an increase of C3 and Bf protein levels
both in the mothers and early embryos [201].

Antimicrobial peptides
Antimicrobial peptides are small cationic peptides of less than 100 amino acids
that are an important component of the innate immunity, and are found in plants and
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animals [202]. They have a wide bactericidal activity that includes killing of bacteria,
viruses and fungi [203-205]. Small antimicrobial peptide genes such as defensins,
hepcidin and phosvitin have been sequenced and characterized in the zebrafish embryo
[206-209]. While some antimicrobial peptides are constitutively expressed and
synthesized by cells such as keratinocytes, monocytes, neutrophils and epithelial cells,
many are induced [209]. It was demonstrated that phosvitin played an important role in
zebrafish embryos not only as an antimicrobial effector capable of killing microbes but
also by acting as a pattern recognition receptor recognizing PAMPs of Gram-negative
and Gram-positive bacteria [208]. Hepcidin gene expression was shown to be increased
in fish that developed signs of bacterial infection [206].

Antisense morpholino knockdown of innate immunity mediators
Morpholinos are the most commonly used tool to knockdown genes in the
zebrafish embryo. While some morpholinos work by specifically binding near the 5’ UTR
of the target RNA to block the access to the ribosomal initiation complex thus inhibiting
protein translation, others work by blocking pre-mRNA splicing. In either case, the effect
of morpholinos is most effective when injected at the 1- to 2- cell stage of the embryo; it
results in a variable period (4 to 7 days) of transient knockdown of specific genes
allowing researchers to study their role in zebrafish [210,211]. The role of MyD88, the
most common adaptor for TLR signaling, in response to S. typhimurium infection in the
zebrafish embryo was studied using a morpholino knockdown approach [180]. The
induction levels of irak3, mmp9 and il-1b were shown to be significantly suppressed in
the MyD88 morphants [180]. The Spi1/Pu.1 transcription factor is important for normal
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development of the myeloid cell lineage, and morpholino knockdown of this gene results
in embryos lacking macrophages and neutrophils [212]. Therefore, morpholino
knockdown of this gene has often been used for infection studies in the zebrafish
embryo model. These morphants showed increased susceptibility to infection with
bacteria such as P. aeruginosa, E. coli and S. aureus [105,106,213,214]

1.7. Zebrafish adaptive immune system
While the zebrafish embryo has a fully mature innate immune system by 48 hpf,
the adaptive immune system is not fully developed until 4- to 6- weeks post-fertilization
[215]. However, B cell and T cell progenitors begin undergoing recombination activating
gene (rag-)-dependent rearrangements within the kidney and the thymus, respectively,
by 4 dpf [103]. Evidence for the existence of dendritic cells (DCs) and their function as
professional antigen presenting cells (APCs) have been reported in the zebrafish
[117,216]. As in humans, B cell and all T cell types, CD4+ T cells, CD8+ T cells and
CD4+ CD25+ T regulator cells, have been described in zebrafish although their
functional studies in the zebrafish are still lacking [217]. The adaptive immune response
to infection initiates with APCs presenting processed foreign peptides derived from
microbes to lymphocytes [217]. It is speculated that this process occurs primarily in the
spleen, the secondary lymphoid organ of the zebrafish where DCs reside [117], and can
also take place in the gut, where large numbers of DCs and lymphocytes can be found
[218,219].
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1.8. Zebrafish vasculogenesis and angiogenesis
The zebrafish circulatory system is as complex as that of mammals. Zebrafish
vascular formation is composed of two main processes: vasculogenesis and
angiogenesis.

Like

other

vertebrates,

zebrafish

vasculogenesis

involves

the

differentiation of lateral mesoderm to hemangioblasts which then differentiate into
angioblasts and endothelial cells [112]. Angiogenesis, on the other hand, is the process
through which new blood vessels are formed from existing vessels. It occurs during
normal tissue growth and repair; it involves the activation and division of endothelial
cells within an existing vessel inducing enzymatic activities that cause local breakdown
of the vessel and the subsequent sprouting of new vessels [112]. The expression of
hemangioblast markers such as the endothelium-specific receptor tyrosine kinase
VEGFR2/Flk1 and the stem cell leukemia protein (SCL/Tal-1) have been detected in the
lateral mesoderm of the zebrafish embryo by 12 hours post-fertilization [220,221]. By 24
hpf, the zebrafish embryo develops a simple blood circulation loop in which the blood
from the dorsal aorta and axial vein circulates through the yolk sac circulating valley
prior to returning to the heart. Then by 72 hpf, a complete vascular system is formed
containing the intersegment vessels (ISVs) of the trunk stemming from the dorsal aorta
and the subintestinal vessels (SIVs), which are originated from the Duct of Cuvier
through angiogenic processes [110].
Angiogenesis plays a critical role in tumor growth and metastasis and many
genes that are involved in angiogenesis in higher vertebrates and mammals have also
been identified in the zebrafish embryo. Among them are the VEGF and its tyrosine
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kinase receptors (Flk-1 and Flt-1), and angiopoietin [222-224]. The vegf-A gene and its
splicing isoforms, including the two dominant forms in vegf-A165 and vegf-A121, have
been isolated and characterized in the zebrafish embryo [222,225]. The role of VEGF in
vasculogenesis, angiogenesis, and hematopoiesis in the development of the zebrafish
embryo has been studied. Liang et al. demonstrated that the overexpression of both
isoforms resulted in early onset and increased transcript levels of endothelial cell
markers (flk1, tie) and hematopoietic cell lineage markers (gata1, scl) [226]. Several
studies show that overexpression of vegf leads to ectopic vasculature in the developing
zebrafish embryo, which occurs via the interaction of VEGF with FLK1 and sydecan-2
receptors [226-228]. Moreover, VEGF has been shown to be upregulated in
pharmacologically induced vessel sprouting as well as pathologically induced
angiogenesis in the zebrafish embryo [108,110,229-231].
At least three homologs of mammalian angiopoietin genes (ang1, ang2, and
angptl3), and the endothelium-specific tyrosine kinase receptors (tie1 and tie2) have
been isolated in the zebrafish by Pham et al. and Lyons et al. [223,232]. Their
transcripts were shown to be present in all EC of both developing and mature blood
vessels. Furthermore, three angiopoietin-like proteins (angptl1, angptl2 and angptl6),
homologous to human angiopoietin-like proteins, were isolated and characterized in the
zebrafish embryo by Kubota et al. [233]. Contrary to angiopoietin signaling which occurs
through Tie 1 or Tie 2 receptors, angiopoietin-like proteins do not interact with the Tie
receptors. Another study by Kubota et al. has shown that cooperative interactions of
Angptl1/2 play an important role in vascular development and angiogenesis [234]. They
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were shown to bind endothelial cells displaying antiapoptotic activities via the PI3-K/Akt
pathway in vitro [234].
Several vascular-specific transgenic lines of the zebrafish embryo including
Tg(fli1:EGFP),

VEGFR2-GFP,

and

Tie2-GFP

have

been

developed.

The

Tg(fli1:EGFP)y1 strain, which expresses green fluorescent protein in the vasculature,
has been used to model tumor angiogenesis using mammalian tumor xenografts as well
as human metastatic melanoma cells [108,109]. Those reports and others showed
evidence of tumor cell growth accompanied with the disruption of normal vessel pattern;
sprouting of the vessels and tumor metastasis as seen in mammals [108,109,235].
The angiogenic response in the zebrafish embryo model is often quantitatively
assessed by measuring the size, the length and the branching of the blood vessels
[110,236]. Moreover, quantitative real-time PCR (qRT-PCR) and ELISA methods to
assess changes in gene expression in response to angiogenic stimuli are sometimes
used to complement phenotypic observations in the zebrafish embryo model [237,238].

1.9. Objective
Bh causes a wide range of infection in human, but it is known mostly for its
unique

ability

to

cause

bacillary

angiomatosis,

a

disease

characterized

by

vasoproliferative tumor-like lesions in some immunosuppressed individuals. Over the
past 15 years, Bartonella research has been advancing at a fast pace due in part to the
availability of the complete genome sequence for Bh [73]. This has enabled the
establishment of gene function and definition of important virulence factors associated
with Bh-induced pathogenesis. Although much is known about Bh and those virulence
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factors from studies using in vitro systems, their molecular mechanisms and overall
contribution to Bh pathogenesis remains elusive and can only be fully understood by
using an in vivo model. Therefore, there has been a great need for a practical animal
model to study Bh pathogenesis and host response. To date, efforts to establish an in
vivo model to study Bh pathogenesis have for the most part been unsuccessful. We
proposed to use the zebrafish embryo to study Bh infection and host response. Based
on our literature review and our preliminary data, we hypothesized that: the zebrafish
embryo is a suitable model of transient infection with Bh requiring the action of
the adhesin BadA and the type IV secretion system and is ultimately cleared by
the innate immune response of the embryo.
In order to test this hypothesis, the following objectives were developed and studied:
1) Define the optimal conditions necessary to maintain the longest possible
sustained infection of zebrafish embryos with Bh
2) Examine the zebrafish response to Bh infection
3) Determine if the trimeric autotransporter Bartonella adhesin A (BadA) and the
VirB/VirD4 T4SS are required in Bh infection in the zebrafish embryo in vivo
model
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Chapter 2
Materials and Methods
2.1. Bacterial strains and growth conditions
The DsRed2 labeled kanamycin-resistant Bh strains were cultured on heart
infusion agar (Remel, Thermal Fisher Scientific, Lenexa, KS) supplemented with 1%
bovine hemoglobin (chocolate agar) (Remel, Thermo Fisher Scientific, Lenexa, KS) and
50 µg/ml of kanamycin or in Schneider’s liquid medium (Sigma-Aldrich, St Louis, MO)
supplemented with 10% fetal bovine serum and 50 µg/ml of kanamycin for 3-4 days at
37ºC in the presence of 5% CO2 [239]. Escherichia coli (E. coli) strains were grown in
Luria-Bertani (LB) broth or agar at 37ºC with no CO2. All manipulations of infectious
agents in this project were approved by the USF Institutional Biosafety Committee.

2.2. Animal care and strains
Transgenic zebrafish embryos Tg(mpx:GFP)uwm1 were purchased from
Zebrafish International Resource Center (Eugene Oregon). Adult breeders of the
transgenic line Tg(fli1:egfp)y1 were a kind gift from Dr. Brandt Weinstein (NCI, Rockville,
MD). Zebrafish breeders were maintained at 28 ± 0.5°C in a 14h:10h light/dark cycle in
our breeding system designed by Aquatic Habitats (Apopka, FL) in accordance with
standards established in the “Zebrafish Book” [240]. In the evening adult breeders were
placed in a 1.5 ml breeding tank in a female to male ratio of 1:1 or 2:1 separated with a
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divider. The next morning the divider was removed to allow mating and egg production.
The eggs were collected and transferred to the laboratory where they were washed with
0.065% of bleach in zebrafish embryo water and rinsed three times with fresh embryo
water. After washing, the unfertilized eggs were discarded and the fertilized eggs were
kept in fresh embryo water containing 2 µM of methylene blue at 30°C overnight.
Methylene blue helps inhibit growth of fungi in the water. Infected embryos were kept at
30°C for a week post-fertilization.

2.3. Ethics Statement
This study was performed in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Zebrafish embryos and adults were maintained in accordance with standards
established in the “Zebrafish Book” [240], and by the guidelines outlined by the
Institutional Animal Care and Use Committee (IACUC) at the University of South
Florida. The experiments using zebrafish embryos described in this report were
approved by the USF IACUC under protocol R4174.

2.4. Construction of Bh knockout mutants
Bh genomic DNA extraction
Bh genomic DNA was prepared using our standard laboratory protocol to extract
genomic DNA from Bh. One quarter to half plate of 3 to 4 day growth bacteria was
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harvested in 400 ml of 1x Tris EDTA (TE) buffer (pH 7.5), and the bacteria were lysed
in a 1% final concentration of sarkosyl and 100 µg/ml final concentration of proteinase K
for 90 minutes at 55°C. After cooling down to room temperature (RT), the sample was
extracted through a series of steps of phenol/chloroform treatment and centrifugation at
16,000 x g for 3 minutes using an Eppendorf Centrifuge (USA) – the sample was
treated with 1 volume of saturated phenol (pH 6.6) twice followed by chloroform
(chloroform/isoamyl alcohol 24:1) treatment 2 to 4 times or until the top layer which
contained the DNA was clear, which then followed by a final chloroform
(chloroform/isoamyl alcohol 24:1) extraction. The DNA was then precipitated in 0.1
volume of 3 M NaOAc and 2.5 volume of absolute ethanol (EtOH) overnight at -20°C.
The precipitate was spun down for 30 minutes at 16,000 x g at 4°C and the supernatant
was discarded. The pellet was rinsed with cold 70% EtOH and spun at 16,000 x g for 5
minutes. The supernatant was discarded and pellet was dried in a Speed Vac SC100
(Savant Instrument, Inc., Hicksville, N.Y.) for 10 minutes. The DNA was then
resuspended in 30 µl of TE/RNAse (0.2 mg/ml of RNAse). Note that the TE/RNAse
solution was heated at 80°C for 20 minutes to inactivate any contaminating DNAse.

Preparation of plasmid DNA from E. coli
E. coli was inoculated in LB broth and grown overnight at 37°C with shaking at
220 RPM. Plasmid DNA extraction was prepared using the Pure Yield Plasmid Midi
Prep System according to the manufacturer’s instruction (Promega, Madison, WI).
Briefly, overnight culture was pelleted by centrifugation at 5000 x g for 10 minutes. The
pellet was resuspended in Cell Resuspension Solution and an equal volume of Cell
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Lysis Solution was added. The mixture was inverted 3 to 5 times and incubated for 3
minutes at RT. Neutralizing Solution was added to neutralize the lysis solution by
inverting the sample and incubating for 3 minutes to allow proteins and cellular debris
precipitation. The sample was then purified using a Pure yield Cleaning Column and
centrifugation at 1500 x g for 5 minutes to separate the solution containing the DNA
from the debris. The sample was then added to a Pure Yield Binding Column and spun
at 1500 x g for 3 minutes to bind the DNA to the column. The column was washed with
Endotoxin Removal Wash Solution containing isopropanol. The sample was spun at
1500 x g for 3 minutes and the column was washed again with Column Wash Solution
containing EtOH and was spun as before followed by centrifugation at 1500 x g for 10
minutes to ensure that residual EtOH was removed. To elute the DNA, the column was
placed in a new tube, followed by the addition of nuclease-free water and centrifugation
at 2000 x g for 5 minutes.
In-frame deletion mutants of the full length badA (BH01510) and the virB operon
(virB2-virB11) were constructed in Bh Houston-1 using the two-step mutagenesis
strategy described by Mackichan et al. with some modifications [241]. Bh genomic DNA
was used as template for PCR to generate two fragments of the gene. The first
fragment contained an upstream noncoding region and included a small segment of the
5’ part of the gene whereas the second fragment contained a downstream region and a
3’ segment of the gene. The two purified PCR products were used as templates for
megaprime PCR using only the forward primer from fragment 1 and the reverse primer
from fragment 2. The resulting product was purified and ligated into the “suicide”
plasmid pJM05 at the BamHI restriction site.
34

The plasmids containing the deleted gene were transformed into DH12S E. coli
(Life Technologies) and then incorporated into Bh Houston-1 by transconjugation using
a two-step allelic exchange strategy [241]. The pJM05 derivative integrated into the Bh
chromosome by homologous recombination with the sequences flanking the target
gene. Transconjugates were selected by plating on 5% rabbit blood agar supplemented
with kanamycin (30µg/ml), nalidixic acid (20µg/ml), and cefalozin (2µg/ml). The colonies
were then counter-selected on agar containing 10% sucrose to promote excision of the
integrated plasmid by a second cross-over event resulting in replacement of the full
length gene with the truncated version. PCR was performed on genomic DNA isolated
from kanamycin-sensitive sucrose-resistant colonies to confirm the knockout genotype.
The deletion mutants were verified by sequencing across the deleted region and by
performing RT-PCR to ensure the absence of the mRNA from the mutants.

2.5. Construction of red fluorescent protein expressing strains of Bh
The plasmid vector pDsRed2 (Clonetech, Mountain View, CA) was used as a
template to amplify the Discosoma sp. dsred2 gene for cloning into pNS2T5 vector
containing a kanamycin resistance gene [242]. The amplicon was digested with BamHI
and XbaI (New England Biolabs) and then ligated into similarly digested pNS2T5 such
that the dsred2 gene was expressed as a 6xHis tagged fusion protein. The resulting
plasmid, pNS2T5-DsRed2, was electroporated into Bh Houston-1 wild-type, ΔbadA, and
ΔvirB

mutants

making

red

fluorescent
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protein

(RFP)-expressing

strains

Bh/pNS2T5DsRed2,

BhΔbadA/pNS2T5DsRed2,

and

BhvirB/pNS2T5DsRed2,

respectively.
A chromosome knock in strain of Bh Houston-1 expressing DsRed2
(Bh::DsRed2) was constructed by cloning of the T5 promoter-dsred2 into the
multicloning site (MCS) of EZ-Tn5 pMOD-6<Kan-2/MCS> transposon construction
vector (EPICENTRE, Madison, WI). The KanT5 DsRed transposon DNA was amplified
by PCR and purified using the Wizard SV Gel and PCR Clean-up System according to
the manufacturer’s instructions (Promega). The stable transposome was prepared with
the transposon DNA and the transposase enzyme according to manufacturers’ protocol
and electroporated into Bh Houston-1. After kanamycin selection, transposon knock in
strains were identified by confocal microscopy as those expressing RFP. Further, the
clones were subjected to inverse PCR and sequencing methodology to confirm that the
DsRed2 transposon was not inserted into an important gene. It was determined that the
knock-in strain selected for further use had the transposon introduced in the intergenic
region upstream of the hypothetical protein BH14030 and downstream of BH14040.
Growth curve experiments showed no difference in growth between the chromosomally
inserted DsRed2 or the plasmid encoded DsRed2 Bh Houston-1 strains when
compared to WT Bh (data not shown).

2.6. Zebrafish embryo staging and microinjection
Before microinjection, embryos were staged at 24-28 hours post-fertilization (hpf)
and manually dechorionated using two pulled-glass needles under a dissecting scope
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(Nikon). Embryos were anesthetized in 0.02% tricaine methanesulfonate (Sigma) in
embryo water [240]. Microinjection needles were pulled from 1.0-mm borosilicate glass
micropipette using the PC-10 vertical puller (Narishige).
Bh and E. coli cultures were pelleted by centrifugation at 3000 x g for 5 min and
resuspended in 0.05% phenol red in phosphate-buffered saline (PBS; pH=7.4) to help
monitor the microinjected solution. The suspension was serially diluted and plated to
determine the number of colony forming units (CFUs) indicating the number of viable
bacteria. All Bh plates were incubated at 37°C with 5% CO2 for 10 days; E. coli bacteria
were plated on LB agar and incubated overnight at 37°C. For microinjection,
anesthetized embryos were placed into a holding groove in 3% agarose to immobilize
them for microinjection. Embryos were microinjected in the yolk sac or the blood
circulation using thin pulled-glass needles attached to a Kite micromanipulator (WPI,
Sarasota, Florida), a PV830 pneumatic pump microinjector (WPI, Sarasota, Florida),
and a SMZ 1500 dissecting microscope (Nikon). To determine the infection doses,
bacterial suspensions were expelled into microcentrifuge tubes containing 1X PBS
before, during and after microinjection and plated for CFU enumeration or saved for
qPCR experiments. For angiogenic response experiments, positive control embryos
were injected with 10 ng of recombinant zebrafish VEGF (rzfVEGF) (R&D Systems;
Minneapolis, MN).
2.7. Digital imaging and microscopy of zebrafish embryos
To monitor bacterial infection and host interaction in real time, embryos from the
experimental and control groups were anesthetized and suspended in a depression
37

slide in 0.05% agarose/embryo water. Live embryos were examined with a 20x LUC
Plan FLN 0.45 N.A. objective using an Olympus FV1000 confocal laser scanning
microscope (Olympus America, Center Valley, PA). EGFP-vasculature of the embryo
and DsRed2-expressing bacteria were imaged by a 488 nm laser with 475-519 nm
spectral emission setting and a 543 nm laser with 525-615 nm emission, respectively.
For time-lapse imaging, live embryos were viewed with a 20x UPLSAPO 0.75 NA, WD
0.65mm objective using an Olympus IX81 inverted microscope equipped with the 3i
Yokogawa spinning disk scanner and CDD cameras. Some pictures were viewed using
the FluorView 10-ASW 1.7 and analyzed by using the NIH ImageJ software. Others
were analyzed using the SlideBook 5.5 software and the SMRecorder software to make
3D surface view videos showing the interaction of the RFP-expressing bacteria and the
GFP-expressing endothelial cells. Adobe Photoshop CS5.1 software was subsequently
used to arrange and format the images and all micrographs were reported as projected
z-series.

2.8. Bacterial enumeration from zebrafish embryos
Bh infection and viability in the zebrafish embryo host were determined at
different time-points after infection. Three to five embryos from of the infected and
control groups were washed 3 times with 1X PBS and transferred to 1.5 ml tubes.
Whole embryo tissues were disrupted in 0.1% saponin/PBS solution using sterile
disposable plastic pestles. The suspension was serially diluted and plated on chocolate
agar plates containing 50 μg/ml of kanamycin. The plates were incubated at 37°C with
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5% CO2 for 10 days to determine number of CFUs. The means of triplicate samples
were used for comparison between experimental and control groups at different time
points.

2.9. Genomic DNA extraction and qPCR
Infected and control zebrafish embryos were individually stored at -80°C at
different time points for genomic DNA extraction. Embryos were homogenized
individually and total DNA was extracted using the Wizard Genomic DNA Purification Kit
(Promega) according to the manufacturer’s instructions for extracting genomic DNA
from animal tissue and Gram-negative bacteria with slight modifications. Before the last
isopropanol precipitation step, 5 μg of glycogen was added to help precipitate the
nucleic acid. The final DNA pellet was resuspended in 20 µl of TE. To construct a
standard curve, known amounts of Bh genomic DNA purified by the same procedure
were utilized as template for qPCR. The genome equivalent (GE) per microliter/template
was calculated by dividing the concentration (g/µl) of the extracted DNA by the
molecular weight of the Bh genome (2.08 x 10-15 g/copy). The bacterial nucleic acid was
serially diluted to generate standards facilitating conversion of real-time PCR cycle
threshold values to Bh NADH dehydrogenase gamma subunit G gene (nuoG)
(BH08890) copies per embryo. Quantitative polymerase reactions (qPCR) were run in
25 μl volume reactions containing 12.5 μl of 2X iQSYBR Green Supermix, 300 nmol of
each primer, and 5μl of extracted DNA using the cycling parameters as follows: 95°C for
3 min, followed by 40 cycles of 60°C for 30s and 55°C for 1 min. The primer sequences
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for qPCR were as follows: nuoG forward 5’-GGCGTGATTGTTCTCGTTA-3’; nuoG
reverse 5’- CACGACCACGGCTATCAAT-3’ [243]. A melting curve analysis was
performed to confirm that no primer-dimers were amplified. All samples were run in
triplicate, and the average GE for 5 embryos was calculated.

2.10. Antibacterial activity
In order to induce the production of antimicrobial factors, zebrafish embryos were
staged at 28 hpf and inoculated in the yolk sac with Bh. Pools of 20 embryos were
saved at -70°C at day 4 post-inoculation and homogenized with a pellet pestle. The
lysate was spun down at 3500 x g for 5 minutes at 4°C to remove the debris. The
supernatant was collected into a 1.5 ml tube and filtered through a pre-wetted 0.45μm
filter to remove any bacterial contaminant including Bh. HMEC cells were also
harvested to use as a control. HMEC cells were cultured without antibiotics in a flask
and washed 5 times with 1X PBS to remove growth supplements. HMEC lysates were
sonicated using a Sonic Dismembrator 120 (Fisher Scientific) for two minutes in 15
seconds interval at 30% setting on ice. The lysate was processed as was done for
zebrafish lysate. The filtered supernatants were then transferred into YM-3 centricons
(Millipore, USA) and spun at 4,000 x g for up to 40 minutes at 4°C to concentrate the
protein. YM-3 centricons have a 3,000 nominal molecular weight limit (NMWL) cut-off,
which allows the retention of small antimicrobial peptides. The amount of protein in the
lysate was calculated by a BCA protein assay. Bh culture was prepared in Schneider’s
medium and seeded into 3 sets of triplicate wells in a 96-well plate. Embryo lysates
were added into one set of triplicate wells as the experimental group, HMEC lysates
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were added into another set of triplicate wells and 1x sterile PBS was added into the
last set of triplicate wells. The 96 well-plate was sealed and incubated at 30°C for up to
5 days.

2.11. RNA isolation
Pools of 10 embryos were stored at -80°C for RNA extraction and purification as
described by Leung et al. [244]. Briefly, frozen embryos were homogenized with Trizol
Reagent (Invitrogen, Grand Island, NY) using an RNAse-free Kontes pellet pestle
(Fisher Scientific, Pittsburg, PA). The samples were spun at 21,000 x g for 2 minutes in
a

QIAshredder

column

(Qiagen,

Valencia,

CA)

for

further

homogenization.

Subsequently, total RNA was extracted twice with chloroform (chloroform/isoamyl 24:1)
in Heavy Phage Lock Gel tubes (Fisher Scientific, Pittsburg, PA) to separate the
aqueous phase from the organic phase. The extracted RNA was then purified using the
RNeasy MinElute Cleanup kit (Qiagen, Valencia, CA) according to the manufacturer’s
instructions. The RNA was eluted using diethylpyrocarbonate (DEPC)-treated water.
The RNA was subsequently treated with Turbo DNAse (Ambion) according to the
manufacturer’s protocol. The yield and the integrity of the extracted total RNA was
evaluated by measuring the ultraviolet (UV) absorbance using the ND-1000 nanodrop
spectrophotometer (Thermo Scientific, Wilmington,
electrophoresis.
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by agarose

gel

2.12. Microarray
The microarray experiments and data analysis were performed in the Moffitt
Cancer Center and Research Institute Molecular Genomics Core Facility. RNA from
pools of Bh-infected and control embryos was isolated as described above. The
resulting RNA (100 ng) was used as a template to generate amplified complementary
DNA (cDNA) via a three-step process called Ribo-SPIA™ using the Ovation® Pico WTA
System V2 kit and the WT-Ovation® Exon Module according to the manufacturer’s
instructions (NuGEN Technologies, San Carlos, CA) and as described by Clement-Ziza
et al. [245]. The hybridization mixture was prepared to accommodate 5 µg of cDNA
target. The Zebrafish Gene 1.0 ST Arrays were hybridized, washed, and stained
according to the Affymetrix protocol. The arrays were scanned using a GCS3000 7G
scanner (Affymetrix) and images (DAT files) were converted to CEL files using AGCC
software (Affymetrix). Robust Multi-array Average (RMA) data analysis was performed
using expression console V1.2 Affymetrix. Differential gene expression analysis was
performed using Excel.

2.13. cDNA synthesis and qRT-PCR
The DNAse-treated RNA (1 µg) was reverse transcribed into cDNA in a 20 µl
reaction using the iScript cDNA Synthesis Kit (Bio-RAD). Real-time PCR was performed
using the iCycler IQ real-time PCR detection system (Bio-Rad). Each reaction was
performed in a 25 μl volume containing 2 µl (100 ng) of cDNA, 12.5 μl of 2X iQSYBR
Green Supermix (Bio-Rad) and 300 nmol of each primer. All reactions were performed
in triplicate, and zebrafish elongation factor -1 (elf1α) or ribosomal protein L13 (rpl13)
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was used as endogenous gene for normalization. Cycling parameters were 95°C for 3
min, followed by 40 cycles of 60°C for 30s and 55°C for 1 min. Melting curve analysis
was performed to confirm that no primer dimers were amplified. Results were analyzed
using the comparative CT method (2-∆∆Ct) [246].

2.14. Statistical analysis
The SigmaPlot 11.0 software was used to graph and statistically analyze the
data. One Way Repeated Measures of Analysis of Variance (One Way Repeated
ANOVA) test was used to assess the significance in the increase in bacterial burden at
different time points post-infection. Student’s t-test was used to determine the
significance of the angiogenic phenotype difference in the mean values of the
intersection points (IPs: are the intersections where the subintestinal vessels branch
out) and the number and length of the subintestinal vessel among the infected and the
control groups. The Mann Whitney Rank-Sum Test was used to analyze the difference
in the infectivity of Bh WT compared to the ΔbadA mutant at the different time points.
The error bars represent the standard error of the mean.
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Chapter 3
Results
3.1. Zebrafish embryo–site of injection with Bh and incubation condition
In most zebrafish infectious disease models, infection is achieved by
microinjecting the microbe into the embryo. However, zebrafish infection by immersion
has been achieved by some natural fish pathogens as is the case for Edwardsiella tarda
[173]. We attempted to infect dechorionated zebrafish embryos at 24 hours postertilization (hpf) by static immersion for 16 hours with 108 CFU/ml of Bh Houston-1 (WT)
carrying a plasmid expressing red fluorescent protein (Bh/pNS2T5DsRed2). Results
from confocal microscopy and colony forming unit (CFU) counts from homogenate
plating of embryos were negative for Bh (data not shown). Therefore, we used a
microinjection technique as the means of introducing the bacteria into the embryos.
Since zebrafish optimal temperature is 28.5°C and Bh are exposed to 37°C in the
human host, we assessed the infection pattern in infected embryos kept at constant
temperatures of 28.5°C versus those that are kept at 30°C or 33°C. No significant
difference in infection pattern was observed, and the proper development of the
embryos did not seem to be compromised (data not shown). For all subsequent
experiments, embryos were kept at 30°C to allow for both sufficient bacterial growth and
to maintain the health of the embryos.
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For most bacteria studied using the zebrafish embryo model, infection is
achieved by microinjection via different sites depending on the type of experiment being
performed. Microbes can be injected in the yolk sac, the posterior blood island or the
Duct of Cuvier (yolk sac circulating valley) to initiate systemic infection, whereas a local
infection can be achieved by injecting the microbes into the hindbrain, the tail muscle, or
the otic vesicle (Fig. 3.1A) [107,118,130,247,248]. In an effort to determine the optimal
infection route, Tg(fli1:egfp)y1 transgenic embryos were staged at 28 hpf and
microinjected either in the yolk sac or the blood circulation valley with approximately 3 x
103 CFU of Bh Houston-1 (WT) expressing red fluorescent protein from a single
transposome inserted into the chromosome (Bh::DsRed2). Bacteria injected in the blood
circulation were cleared by day 2 post-injection (dpi) as shown by the DsRed2 signal,
whereas those inoculated in the yolk sac near the developing subintestinal vessels
replicated and persisted throughout the duration of the experiment (3 dpi) (Fig. 3.1B).
A

B

Figure 3.1 Zebrafish embryo injection site with Bh. A). Schematic representation
of the zebrafish embryo at approximately 48 hpf highlighting the possible sites of
injection (not drawn to scale). B) Representative micrographs of embryos inoculated
in the yolk sac circulation valley (row 1) or the yolk sac (row 2) at 28 hpf with an
average of 3 x 103 CFU Bh::DsRed2. The same embryos were photographed by
confocal microscopy at the indicated time points. Scale bar = 100 µm.
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3.2. Bh infection and survival in the zebrafish embryo host
In order to assess Bh infection and viability in the zebrafish embryo host,
Tg(fli1:egfp)y1 transgenic embryos were staged at 28 hpf and microinjected in the yolk
sac near the developing subintestinal vessels with 3 x 103 genomic equivalents (GEs) of
Bh::DsRed2. Microscopy results showed an increase in bacterial burden with peak
fluorescence observed on day 3 post-infection (dpi) and persistence through the entire
duration of the experiment (6 dpi) (Fig. 3.2).

Figure 3.2. Live imaging of zebrafish embryos infected with Bh. Confocal
imaging of embryos inoculated with 3 x 103 GEs of Bh::DsRed2 (row 1) or PBS
phenol red control (row 2) by microinjection into the yolk sac. All images shown
are representatives of the pool of embryos photographed. Scale bar = 100 µm.

To determine the viability of the bacteria in the host, embryos were inoculated
with approximately 5 x 103 CFUs or PBS phenol red control, and three embryos were
homogenized individually and plated in triplicate on selective kanamycin chocolate agar
plates (50 µg/ml) at different time points post-infection for bacterial enumeration.
Results showed an increase in CFU count which peaked at 3 dpi and started
decreasing at 4 dpi (Fig. 3.3A). An alternative qPCR method using primers specific to
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the Bh NADH dehydrogenase subunit G gene (nuoG, BH08890) was used to determine
GEs/embryo. Embryos microinjected at 28 hpf with approximately 3 x 103 GEs of Bh
were homogenized; the bacterial nucleic acid was extracted and the GE/embryo was
determined by qPCR. Embryos mirrored the infection pattern observed by confocal
microscopy and plating with bacterial burden increased by almost 10-fold by day 3 (*p =
0.02) and persisted in the embryos for 8 days (Fig. 3.3B). The limit of detection of the
assay was approximately 10 copies of nuoG per reaction and the sequence was not
amplified from the uninfected control embryos (data not shown).
A

B

Figure 3.3. Bh infection and survival in the zebrafish embryo host (A) Average
CFUs (± SEM) from homogenate plating of embryos inoculated with approximately 5
x 103 CFUs of Bh. (B) Average GE/embryo determined by qPCR in embryos
inoculated at 28 hpf with approximately 3 x 103 GEs of Bh. Values are the means (±
SEM) of triplicate wells for 5 different embryos at the indicated time points.
Significant increase in bacteria burden was observed from day 0 to day 2 with **p =
0.013, from day 0 to day 3 with *p = 0.02 and from day 0 to day 4 with ***p = 0.002.
As expected the nuoG sequence was not amplified from uninfected control embryos.

3.3. Bh interaction with zebrafish embryo vascular endothelium
Tissue samples from patients with BA lesions revealed the presence of immature
capillaries that are lined with inflamed endothelium and filled with bacterial aggregates
47

[60,61]. Therefore, the location of the bacteria, or bacterial aggregates, in relationship to
the vascular endothelial cells in infected Tg(fli1:egfp)y1 embryos was determined by
confocal microcopy (Fig. 3.4). Microscopy evidence showed that some of the red
fluorescent Bh were colocalized with the green fluorescent angioblasts, the precursor of
vascular endothelial cells, at day 1 post-infection (Fig. 3.4B), and with the mature
vascular endothelium at day 2 post-infection (Fig. 3.4C) as shown by the arrows in inset
images S1 and S2 at the respective time points. However, subsequent analysis was
necessary to ascertain whether the bacteria were located either inside or merely
interacting with the host cells. The SlideBook 5.5 software was used for threedimensional analysis of the micrographs and videos were made using the SMRecorder
software. Analysis showed that aggregates of bacteria were interacting with the EC;
some were inside of the cells while most were located outside or away from the
endothelium (data not shown).

3.4. Recruitment and accumulation of phagocytes to the site of infection with Bh
Bh-induced angiogenic lesions in HIV patients have been shown to be infiltrated
with phagocytes [60,61]. To investigate if Bh could recruit phagocytes to the site of
infection, we injected Bh::DsRed2 in the yolk sac of Tg(mpx:GFP)uwm1 embryos at 50
hpf, a transgenic zebrafish line that expresses GFP under the neutrophil-specific
myeloperoxidase promoter [235]. Upon microscopic examination of live, infected
embryos using the Olympus IX81 inverted microscope equipped with the 3i Yokogawa
spinning disk scanner and CDD cameras, we observed that the infection induced the
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accumulation and colocalization of neutrophils (bright green) with the bacteria (red) at
the site of infection within 2 hpi (Fig. 3.5; top panel). The number of phagocytic cells
increased during the course of infection as shown by the increase in neutrophils (bright
green) (Fig. 3.5; arrow; top panel) and what we presumed to be macrophages (larger,
light green) (Fig. 3.5, arrowhead; top panel) at day 4 post infection in the infected
embryos. Time-lapse imaging further confirmed our observation with the slow moving
macrophages (data not shown). Macrophages have previously been observed by 24 hpf
in zebrafish embryos based on morphology and phagocytic capacity [118,213,248]. As
observed in the videos, some bacteria were engulfed by the neutrophils and
macrophages; however, most of the bacteria were seen outside of the phagocytic cells.
Compared to the infected embryos the sham injected control embryos did not show as
many phagocytes in the yolk sac (Fig. 3.5; 2 hpi and 4 dpi; bottom panels).

Figure 3.4. Interaction of Bh with GFP-labeled endothelial cells in
Tg(fli1:egfp)y1 zebrafish embryo. (A) Non-infected control embryo at day 1 post
inoculation with PBS/phenol red. (B) and (C) Micrographs of embryos at day 1 and
day 2 post-inoculation, respectively. Insets S1 (scale grid = 50 µm) and S2 (scale
grid = 10 µm) are higher magnification images of the selected area of Bh and EC
interaction. Arrows show areas of adherence and intracellular location of the RFPlabeled bacteria with GFP-labeled EC of the vessels. Images are representatives
of pools of embryos micrographed. Scale bar = 50 µm.
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Figure 3.5. Infiltration and colocalization of GFP-labeled phagocytes with Bh.
Representative micrographs from pools of Tg(mpx:EGFP)umw1 embryos inoculated
at 50 hpf with 300 CFU of Bh WT (top panel) or PBS/phenol red control (bottom
panel) at the indicated time points post inoculation. White arrows are DsRed2 Bh
colocalized with GFP-labeled neutrophils (bright green; 2 hpi and 4 dpi)). Arrowheads
are DsRed2 Bh interacting with macrophages (larger phagocytes) (4 dpi only).
Compared to the infected embryos, minimal numbers of GFP-labeled phagocytes are
observed in the non-infected embryos (2 hpi; 4 dpi). Scale bar = 50 µm.

3.5. Antibacterial activity in zebrafish embryo extract
In an effort to determine if zebrafish embryo extracts possess bactericidal activity
against Bh, extracts from pools of embryos that were primed with Bh were prepared
after 4 days post-inoculation. This time point was chosen due to evidence showing that
the bacteria burden peaked at 3 dpi and started reducing on day 4 or 5 post-infection in
the embryos. HMEC lysate was used as a control. The lysates were filtered and the
amount of protein was quantified by BCA protein assay. The lysates were plated to
ascertain that they were free from bacterial contamination including Bh. An average of
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7.5 x 102 CFU/ml of Bh were co-inoculated with a final concentration of 138 µg/ml of
embryo protein in Schneider’s medium in a 96-well plate. The culture was plated at time
points 0 hr, 3 and 5 days post-exposure to the lysates for CFU count and percent of
bacteria growth inhibition. The data showed that crude embryo lysates did not inhibit the
growth of Bh in vitro; in fact it promoted the replication of the bacteria (Fig. 3.6).
Compared to the PBS control at day 3 post-exposure, the HMEC lysate and the embryo
lysate increased the growth of Bh by 80 and 10,000 fold, respectively. At day 5 postexposure, HMEC increased bacterial survival by 1,875 fold and embryo lysate
increased the bacterial survival by 2,562 fold. This might be due to the presence of
nutrients in the embryo extracts that could help sustain bacterial survival.

Figure 3.6. Bh exposed to crude zebrafish extracts increase bacterial
growth. 7.5 x 102 CFU/ml (± SEM) of Bh was co-incubated with zebrafish lysate,
HMEC lysate or 1 x PBS for 5 days post-incubation. Representative graph
showing Bh exposure to zebrafish embryo lysates and HMEC lysates.
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3.6. Angiogenic phenotype and inflammatory and angiogenic responses in Bh
infected embryos
In order to evaluate the angiogenic effect induced by Bh infection, Tg(fli1:egfp)y1
transgenic embryos were inoculated with an average of 3 x 103 GEs of Bh::DsRed2.
Confocal laser scanning microscopy was used to examine the embryos and evaluate
blood vessel formation and morphology near the site of infection. Infected embryos
were analyzed for vessel sprouting at 48 hpi (Fig. 3.7). Note that the red fluorescent
overlay showing the RFP bacteria in the infected panel (ii) was omitted to help better
visualize the subintestinal basket (the branching network of blood vessels within the
yolk sac), so the inset image represents the same embryo showing the bacteria at the
site of infection. Compared to the uninfected control group (Fig. 3.7A, i) and the
rzfVEGF-injected control group (Fig. 3.7A, iii), blood vessel sprouting, shown by the
white arrows, could be seen at the subintestinal basket of the infected embryos (Fig.
3.7A, ii). The length of the SIVs was measured and the evidence showed a lengthening
of the SIVs in the infected samples compared to the controls (Fig. 3.7B).
Moreover, the phenotypic changes induced by Bh infection in the transgenic
embryos infected with Bh/pNS2T5DsRed2 from an independent experiment were
assessed at day 4 post-infection (Fig. 3.8); the inset image showed the presence of the
red fluorescent bacteria at the site of infection. A larger subintestinal basket was
observed in the infected embryos (Fig. 3.8A, ii, white oval) compared to the noninfected control embryos (Fig. 3.8A, i) and similar to the positive control injected with
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rzfVEGF (Fig. 3.8A, iii), suggesting that the bacteria triggered an angiogenic response
that affected the pattern of the subintestinal vessels (SIVs: vessels located in the oval)
at the site of infection. This response was quantitatively analyzed using the ImageJ
software measuring the length, the number and the intersection points (IPs: are the
intersections where the subintestinal vessels branch out) of SIVs from 6 different
embryos from infected group and 5 different embryos from the control group. Compared
to the negative control embryos, the infected and the positive control embryos had
significantly more SIV (** p < 0.001) and IPs (* p = 0.003) (Fig. 3.8B), as well as
significant lengthening of the SIVs (** p < 0.001 and * p = 0.002 for WT and positive
control, respectively) (Fig. 3.8C).
To determine if the observed angiogenesis was accompanied by a proangiogenic response, the host response to Bh infection was assessed by qRT-PCR
measuring the mRNA level of pro-inflammatory cytokines and pro-angiogenic markers
in pools of 10 zebrafish embryos per group at 3 dpi. Those markers were selected due
to their roles in tumor angiogenesis [230,249,250], and because they have been shown
to be upregulated in Bh infection in in vitro models [1,53,77,83,251-253]. The data
showed that the expression of IL-1b, IL-8 (Cxcl8), zVEGF165 (one of the dominant
spliced isoforms of VEGF in zebrafish corresponding to human VEGF165 [222], Flk1 and
angiopoietin-2 were upregulated by 4- to 23-fold in embryos inoculated with Bh WT
compared to those inoculated with PBS phenol red (Fig. 3.7C).
To determine if this angiogenic response was Bh-specific, embryos were
microinjected at 28 hpf in the yolk sac with an average of 4 x 103 CFU of Bh
pNS2T5DsRed2 or E. coli DH12S/pNS2T5DsRed2. At that particular dose E. coli
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DH12S, a non-pathogenic strain, lead to a lethal infection in >90% of the embryos by 20
hpi versus no death for Bh-injected and sham-injected embryos (data not shown). Our
confocal microscopy showed evidence of dying embryos infected with E. coli compared
to sham-injected and Bh infected embryos (Fig. 3.9). Thus, the lethal infection caused
by E. coli precludes any assessment of an angiogenic response in these embryos.
A

B

C

Figure 3.7. Vessel sprouting and angiogenic marker expression in response to
infection with Bh. (A) Subintestinal vessel morphology of embryos at 48 hpi: i)
PBS/phenol red control; ii) embryos infected with approximately 3 x 103 GEs of
Bh::DsRed2 (the overlay showing the RFP bacteria was omitted to help better visualize
the subintestinal basket); inset image is the same infected embryos showing the
presence of the red fluorescent bacteria at the site of infection; white arrows show SIV
sprouting in the infected embryo; iii) Embryos injected with 10 ng rzfVEGF in the yolk
sac near the developing subintestinal vessel. Images are representative of the pool of
infected and control embryos imaged. Scale bar = 100 µm. (B) Length of SIVs for
infected and control embryos at 2 dpi (measured from 200X images) (C) qRT-PCR of
pro-angiogenic markers in zebrafish embryos infected with Bh. Results are expressed
as the mean fold change in transcript levels of Bh-infected compared to uninfected
control embryos at 3 dpi (n=2).
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B

C

Figure. 3.8. Vessel remodeling in zebrafish embryo infected with Bh. (A) Blood
vessel morphology of Tg(fli1:egfp)y1 zebrafish embryos analyzed at 4 days post
inoculation: i) PBS/phenol red control at 4 dpi; ii) embryos infected with
Bh/pNST5DsRed2 visualized at 4 dpi (the overlay showing the RFP bacteria was
omitted to help better visualize the subintestinal basket); white oval indicates the area
of SIVs remodeling in infected embryos; inset image is the same infected embryos
showing the presence of the red fluorescent bacteria at the site of infection; iii)
embryos injected with 10 ng of rzfVEGF (positive control) in the yolk sac near the
developing subintestinal vessel. Images shown are representative of the pool of 6
embryos photographed from the infected group and 5 embryos photographed from
the control groups. Scale bar = 100 µm. (B) Number of subintestinal vessel (SIV) and
intersection points (IP) forming the subintestinal basket in the yolk sac from 6
embryos (4 dpi) from each group (mean ± SEM), (** p < 0.001; * p = 0.003). (C)
Length (in relative units) of SIVs (measured from 100X images) in the yolk sac from 6
embryos (4 dpi) from infected group and 5 embryos from the control groups (mean ±
SEM) versus negative control, (** p < 0.001; * p = 0.002).
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Figure 3.9. Infection of zebrafish embryo with E. coli versus Bh. Micrographs
of Tg(fli1:egfp)y1 embryos at 24 hpi. Infected embryos were inoculated with an
average of 4 x 103 CFUs of E. coli DH12S pNS2T5DsRed2 or Bh/pNS2T5DsRed2
in the yolk sac at 28 hpf; control embryos were inoculated with PBS/phenol red.
Images are representatives of pools of embryos micrographed. Scale bar 200 µm.

Table 3.1. Primers used for qRT-PCR.
Genes

Sequence (5’- 3’)

il-1b

For ATCAAACCCCAATCCACAGAGT
Rev GGCACTGAAGACACCACGTT

il-8

For TGTTTTCCTGGCATTTCTGACC
Rev TTTACAGTGTGGGCTTGGAGGG

Source
[185]

[185]

Vegf

For TGCTCCTGCAAATTCACACAA
Rev ATCTTGGCTTTTCACATCTGCAA

[254]

flk1

For CACAAGAAGTCCAGCGATCA
Rev CAGGGGACCACAAAATATGG

[237]

angptl2

For GGTCATGGATGTTCCTTCAC
Rev GTCCTGCTCAGTGGAAGGTG

[233]

ef1α

For AGAAGGAAGCCGCTGAGATG
Rev TGTCCAGGGGCATCAATAAT

[105]

For TCTGGAGGACTGTAAGAGGTATGC
Rev AGACGCACAATCTTGAGAGCAG

[255]

rpl13a
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3.7. Bh infection induces expression of genes involved in cytoskeletal
rearrangement, angiogenic and inflammatory responses
The overall response of the zebrafish embryo to Bh was characterized by
analyzing the total mRNA levels in infected embryos compared to controls by
microarray using the GeneChip Gene 1.0 ST arrays designed by Affymetrix. This array
was designed based on the most recent available zebrafish genome sequence. The
gene chips were scanned and data were background adjusted, normalized and
summarized by a Robust Multi-array Average (RMA) algorithm. In total, over 883 genes
were upregulated by 2-fold or more, and 886 genes were downregulated by at least 2fold. While several of those genes are uncharacterized, many of them are involved in
metabolic pathways, inflammatory response (IL1b, complement component c3c) and
tissue remodeling (VEGF, IL-8). The fold change in gene expression of Bh-infected
embryos compared to uninfected control embryos was calculated, and the candidate
genes with a cut-off value of 1.9 or up were selected (Table 3.2). Some genes were
also selected based on the evidence of their differential expression in Bh infection in cell
culture models. A complete excel file of the microarray data can be accessed at
http://www.liebertpub.com/zeb. The microarray result was validated by qRT-PCR on
four genes (il8, il1b, vegf, api5) that are involved in either inflammatory response or
angiogenic response to Bh infection of the zebrafish embryos using the remaining RNA
prepared for the microarray experiment. The qRT-PCR result confirmed the
upregulation of these genes due to infection of the zebrafish embryos with Bh (Table
3.2).
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Table 3.2. Selected genes involved in response to infection with Bh. 1The
description and function of these genes are in humans. Fold change indicates Bhinfected compared to uninfected controls. Some genes have the same function in
zebrafish as in humans; however, the functions of some of these genes have not yet
been fully investigated in the zebrafish model.
Accession
number

Microarray
fold change

NM_001002170

+7.07

Regulate dynamic of
microtubule cytoskeleton

Rho family
GTPase 3a

NM_199522

+2.29

Regulate cytoskeletal
dynamic

Cdc42se1

NM_200060

+2.67

Cytoskeletal assembly

Genes

qRT-PCR
fold change

mapre3b

Description/functions

1

IL-8

XM_001342570

+5.54

+2.6

Facilitates migration of
immune cells to inflammation
site; angiogenesis

IL1b

NM_212844

+1.93

+21.3

Inflammatory response, cell
proliferation and
differentiation

VEGF

NM_001044855

+1.92

+6

Cell proliferation;
angiogenesis

Apoptosis
inhibitor 5

NM_199540

+4.23

+9.22

Prevents apoptosis after
growth factor deprivation

FGF13a

NM_001007399

+6.22

Cell growth; tissue repair

E-cadherin

NM_131820

+2.01

Calcium dependent adhesion
molecule

FGF receptor 1b

NM_001161732

+5.20

Regulation of cell growth,
formation of blood vessels

Complement
component c3c

NM_001037236

-2.46

Promotes phagocytosis
during an inflammatory
response against pathogens

FGF2

NM_212823

-3.78

Cell survival; angiogenesis

NM_207054

-2.18

Regulate transcription of
interferon through the JAKSTAT signaling pathway

Interferon
regulatory factor
2a
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3.8. Infection pattern of Bh ∆badA and ∆virB mutants in the zebrafish embryo
To further characterize Bh infection and the importance of BadA and VirB/VirD4
T4SS in Bh pathogenesis and survival in the zebrafish embryo host, embryos were
staged at 28 hpf and microinjected with 3 x 103 Bh Houston-1 containing in-frame
deletions for full-length badA (ΔbadA/pNS2T5DsRed2) or virB operon (ΔvirB211/pNS2T5DsRed2). Microscopy results indicated that both the ΔvirB mutant and the
ΔbadA mutant could survive in the embryos with peak fluorescence observed at 3 dpi,
although the levels of red fluorescence in the mutants was not as strong as in the wild
type (Fig. 3.10A).
In a subsequent experiment, zebrafish embryos were randomly grouped and
inoculated with an average of 7.4 x 103 Bh pNS2T5DsRed2, 5.4 x 103 ΔvirB2-11
pNS2T5DsRed2, and 6.7 x 103 ΔbadA pNS2T5DsRed2. Bacterial infection was
evaluated by qPCR at different time points. Wild-type bacteria were able to replicate,
with GE increasing to over 2 x 105 in four days and remained detectable throughout the
duration of the experiment. In contrast, the ΔvirB deletion mutant appeared to follow the
same infection pattern but exhibited a reduced number of GE/embryo and a shorter
duration of infection. Further, the ΔbadA deletion mutant did not appear to replicate as
well compared to the WT and the ΔvirB mutant in the infected embryos (Fig. 3.10B).
Although there was some variability in the number of bacteria in the initial inocula,
significantly higher numbers of GEs (** p < 0.016, ** p < 0.016, * p < 0.05, and *** P <
0.008 at days 2, 3, 4 and 5, respectively) were detected in embryos infected with the
WT than observed in those inoculated with ΔvirB and ΔbadA mutants.
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A

B

Figure 3.10. Zebrafish embryos infected with Bh ∆badA and ∆virB mutants. (A)
Confocal micrographs of Tg(fli1:egfp)y1 transgenic embryos infected with 3 x 103 CFU
BhΔbadA/pNS2T5DsRed2 compared to the WT expressing DsRed2. All strains persist
in the embryos at least 5 days post-infection with a peak fluorescence observed at 3
dpi with the fluorescence intensity is at least twice as much in the WT-infected
compared to the mutant-infected embryos. All images shown are representative of the
pool of embryos imaged. Scale bar = 100 µm. (B) Infection pattern in zebrafish
embryos inoculated at 28 hpf with 6.7 x 103 CFU of BhΔbadA/pNS2T5DsRed2 or 7.4 x
103 CFU of Bh/pNS2T5DsRed2 and 5.4 x 103 ΔvirB2-11 pNS2T5DsRed2. The means
of GEs between infected groups were calculated by qPCR at different time points
(mean ± SEM; * p < 0.05, ** p < 0.016 and *** P < 0.008).
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3.9. The Bh ∆badA and ∆virB mutants exhibit an attenuation response in vivo
The response to infection in pools of embryos inoculated with the ∆virB mutant
was investigated by qRT-PCR at day 3 post-infection. Compared to embryos inoculated
with WT those inoculated with ∆virB mutant displayed a reduced induction of IL-8 by
1.6-fold, IL-1 by 1.5-fold, VEGF by 1.7-fold, FLK1 by 1.8 fold and angiopoietin by 10.8fold (Fig.3.11A). In independent experiments, the response to infection in pools of
embryos inoculated with the ∆badA mutant was also assessed by qRT-PCR. Embryos
inoculated with the ∆badA mutant showed a reduced induction of IL-1 by 7-fold and proangiogenic markers IL-8, zVEGF165, Flk1 and angiopoietin-2 by 2.5-fold, 2-fold, 3-fold,
and 2-fold, respectively (Fig. 3.11B). Both mutants displayed diminished ability to
induce a pro-inflammatory response as well as a pro-angiogenic response compared to
the WT. However, except for angiopoietin, a greater difference in expression of those
markers was observed when embryos were inoculated with ∆badA mutant.
A

B

Figure 3.11. Response to infection with Bh ∆badA and ∆virB mutants. (A) Differential
expression in pro-inflammatory genes and pro-angiogenic factors by qRT-PCR in pools of
embryos infected with ΔvirB compared to WT. Results are expressed as the mean fold
change of WT-infected or ΔvirB mutant-infected compared to uninfected control embryos at
3 dpi (n=2). (B) Differential expression in pro-inflammatory genes and pro-angiogenic
factors by qRT-PCR in pools of embryos infected with ΔbadA compared to WT. Results are
expressed as the mean fold change of WT-infected or ΔbadA mutant-infected compared to
uninfected control embryos at 3 dpi (n=2).
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Chapter 4
Discussion
Bartonella are facultative intracellular pathogens with over thirty species
described that infect a range of mammalian hosts [6,8]. Bh, B. quintana and B.
bacilliformis are the species most commonly known to cause human disease.
Depending on the immune status of the infected individual, Bh infection can span the
range of self-limiting cat scratch disease (CSD) to the more serious and life-threatening
bacillary angiomatosis (BA) [7]. A unique aspect of some Bartonella species is their
ability to induce blood vessel proliferation in humans characterized by blood-filled
capillaries resulting from systemic infection [47]. The angiogenic response induced by
Bh in patients with BA is believed to be a multi-step process that involves the
proliferation of endothelial cells, inhibition of endothelial cell apoptosis, and angiogenic
reprogramming of infected host cells. The BadA and the VirB/VirD4 T4SS proteins of Bh
are thought to play a leading role in eliciting an angiogenic host response during
infection [52,76,81,83].
Although much is known about Bh and those virulence factors from studies using
in vitro systems, their molecular mechanisms and overall contribution to Bh
pathogenesis remains elusive and can only be fully understood by using an in vivo
model. Therefore, there has been a great need for a practical animal model to study Bh
pathogenesis and host response. To date, efforts to establish a suitable in vivo model to
study Bh pathogenesis have been unsuccessful. The fact that zebrafish have a well62

developed immune system with many similarities to mammalian systems make them an
attractive model of human diseases. The zebrafish embryo is a proven model for
bacterial pathogenesis; moreover, their transparency and the availability of the
Tg(fli1:egfp)y1 transgenic strain with GFP-labeled vasculature has provided a unique
opportunity to study Bh infection and its distinctive ability to induce vessel proliferation.
We have determined the conditions necessary to maintain a sustained infection
with Bh, including the appropriate route of infection, dose and site of inoculation, the
proper stage of development of the embryos, and the means of enumerating bacteria
after infection. We have found that inoculation of Bh into the yolk sac as compared to
the blood circulation leads to a more persistent infection. It has been reported that yolk
sac infections with fast-growing bacterial species have resulted in massive bacterial
growth and early death of embryos [106,107]. The yolk sac is perhaps preferred by Bh
because it is a fastidious and slow growing bacterium; the yolk sac may provide the
nutrients needed and enough time to adapt to the new environment before facing a
strong antimicrobial response. Furthermore, we have determined that zebrafish
embryos Tg(fli1:egfp)y1 sustained a consistent infection pattern when microinjected at
24 - 28 hpf in the yolk sac with an inoculum of approximately 3 x 103 GEs of Bh.
One area, which proved problematic, was bacterial enumeration of Bh via plating
of embryo homogenates. This assay provides direct counts of the number of viable
bacteria in the embryos. However, the autoagglutination of the bacteria as well as
contamination seen even on kanamycin selective media plates caused some variability
in enumeration as evidenced by the error bars (Fig. 3.3A). This contamination is likely
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in part due to the normal flora present in the embryos. In addition, rapidly growing
water-borne bacteria and fungi that are resistant to kanamycin also proved problematic
since Bh requires at least 5 days for colonies to appear on plates; the contaminants
usually grew much faster and often prevented accurate plate counting. Therefore, we
alternatively used both confocal microscopy to qualitatively visualize Bh in embryos and
qPCR to assess the GE/infected embryo. This method is more sensitive as it uses
primers specific to the Bh NADH dehydrogenase subunit G gene to quantify the
genomic equivalents of bacteria per embryo. It is likely these primers amplify DNA from
nonviable bacteria; however, there is a notable reduction in GEs from day 4 to day 6
suggesting that gDNA from dead bacteria degrades and is not amplified by qPCR (Fig.
3.3B). This reduction pattern in GEs was similar to that observed by microscopy (Fig.
3.2) and by CFU counts in previous experiments (Fig. 3.3A). Despite the possible
detection of nonviable bacteria, the qPCR method proved to be far more consistent and
reliable than the plating method.
Much of the understanding of the mechanisms required for angiogenesis has
been derived from cancer models. Like in cancer, Bh infection of endothelial cells
induces the activation of HIF-1α and subsequent secretion of angiogenic factors such
as VEGF leading to cell proliferation and angiogenesis [76,78]. An in vivo model is
critical since multiple cell types including endothelial cells, macrophages and epithelial
cells are thought to contribute to Bh-mediated angiogenesis via the paracrine loop
model [1,77]. We have shown that aggregates of Bh do interact with the EC of the
embryo with some intracellular bacteria observed. However, many are distant from the
EC in the yolk sac and it is difficult to accurately quantify the number of intracellular Bh
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in infected embryos. It should be noted that in humans, histological studies of samples
from bacillary angiomatosis patients have shown very few intracellular Bh and that most
of the bacteria are seen as epicellular [60].
Histological examination of bacillary angiomatosis lesions from patients with Bh
infection have shown the infiltration of polymorphonuclear cells and macrophages
located in close proximity to the proliferating endothelial layer [60,61]. Our evidence
shows that Bh infection induces migration and accumulation of neutrophils and
macrophages at the site of infection. This result is in agreement with what was observed
in tissue samples as well as what has been shown in in vitro studies revealing the role
of phagocytic cells in Bh pathogenesis [1]. There must be a balance between Bh
causing phagocytic cells to produce proangiogenic factors and at the same time
suppress bacterial killings. Although the yolk sac may be considered as a site of relative
immune privilege in the zebrafish embryo, a robust innate response against infection
has been described in the yolk sac, and macrophages and neutrophils have been
observed ingesting bacteria in both the blood circulation and the yolk sac
[106,107,195,256]. We hypothesize that the resistance to a lethal infection by Bh from
infected embryos is very likely due to the activation of an innate immune response.
While our real-time observation of Bh-infected zebrafish embryos showed an
accumulation of phagocytic cells at the site of infection, the role of these cells in killing
Bh was not clearly demonstrated. It remains to be investigated whether or not this is
due to the ability of this bacterium to inhibit phagocytosis.
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An angiogenic phenotype was observed in our transgenic zebrafish embryo
model when infected with Bh. It was characterized by an increase in length and number
of the subintestinal vessels and intersection points at the site of infection in the infected
compared to controls. Moreover, disruption of the smooth and normal pattern of those
vessels could also be observed. Although the extent of the phenotypic response
observed is not as dramatic as what is seen in tumor angiogenesis, a similar response
was observed in the zebrafish yolk membrane angiogenesis assay developed by Nicoli
et al. [110,257]. The angiogenic phenotype observed in the infected embryos was
further substantiated by qRT-PCR analysis showing the induction of proangiogenic
factors such as IL-8 (Cxcl8), zVEGF-165, zVEGFR2 and angiopoietin-2 in the infected
compared to control embryos. These potent angiogenic factors have been shown to
stimulate EC proliferation and angiogenic phenotypes in response to Bh infection in vitro
[77,251,253]. Our efforts to use E. coli DH12S strain as a negative control for an
angiogenic response in the zebrafish embryo was unsuccessful as embryos inoculated
with E. coli in the yolk sac died within 20 hours post-inoculation. The death of the
embryos may be a result of septic shock due to the high endotoxicity of bacterial
lipopolysaccharide (LPS) of E. coli compared to the remarkably low endotoxicity of LPS
of Bh [90].
Our microarray data provide evidence that there are many genes that are
involved not only in inflammatory and angiogenic responses, but also in cytoskeletal
rearrangement and metabolic processes. This suggests that the bacteria have a
widespread impact on host gene expression patterns. Bh entry into EC and epithelial
cells can happen by two alternative routes: single bacterium uptake via a zipper-like
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mechanism or in the form of large bacterial aggregates in a structure called invasome
[8,54]. The zipper-like mechanism has been documented in several bacteria including
Listeria monocytogenes. It has been shown that the entry of L. monocytogenes into
epithelial cells requires the interaction of the internalin protein with E-cadherin on the
host cell [258]. In addition to its role in cell-cell adhesion and involvement in early tissue
formation in zebrafish embryo [259], E-cadherin may also play a role in Bh entry into the
host cell as Bh infection induces an upregulation of the gene encoding for E-cadherin
protein. Formation of the invasome structure leading to the uptake of Bh aggregates
was shown to be dependent in part on the expression of small Rho family GTPases and
CDC42 [260]. Rho family GTPase 3a and CDC42 small effector 1 (Cdc42se1) were
upregulated in the infected embryos suggesting that they may play a role in Bh-host
interactions.
Antimicrobial peptides such as β-defensins, hepcidin, and phosvitin are an
important component of the innate immunity. In vitro killing of pathogens with purified
antimicrobial peptides from zebrafish embryo extracts have been reported [208,209]. In
vitro exposure of Bh to zebrafish embryo crude extracts promotes bacterial growth,
which may be due to the nutrients found in the embryo extracts. Although we do not rule
out the protective role of antimicrobial peptides in zebrafish extract, it seems like the
nutrients in the extracts outweighs their bactericidal effect on the Bh survival in vitro.
Moreover, Bh infection did not seem to induce their expression in vivo as evidence in
the microarray data showed that their transcript levels did not vary between the infected
and control groups embryos.
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Bh-induced angiogenesis is a multi-step process that partly depends on the
expression of BadA protein which induces proangiogenic cell response via activation of
HIF-1 and NF-kB, and the subsequent secretion of VEGF and IL-8, respectively [76-78].
Bh-induced angiogenesis in the zebrafish embryo may occur through the same pathway
as previously shown in cell culture studies as those genes, including HIF-α
(NM_2002233) and NF-Кβ (NM_203184), were seen to be upregulated in the infected
embryos in the microarray data (data not shown). Some notable genes that were downregulated in the infected embryos include FGF2, which plays an important role in cell
survival and angiogenesis, and complement component c3c, which is involved in
promoting phagocytosis during an inflammatory response against pathogens [261-263].
Although FGF2 expression in Bh-induced angiogenesis has not been fully investigated
in vitro, it is somewhat surprising that the infection with Bh would suppress its
expression. On the other hand, Bh has been shown to inhibit phagocytosis [15], so it is
not surprising that the evidence shows that expression of complement component c3c is
suppressed by Bh infection in the zebrafish embryos.
As in many pathogenic bacteria, the VirB/VirD4 T4SS along with the Bartonella
effector proteins have been shown to play important roles in Bh pathogenesis in vitro
[79,82]. The expression of the VirB T4SS and some of the effector proteins have been
associated with inflammatory cytokine production and pro-angiogenic activities [83,84].
A deletion mutant for genes encoding the VirB T4SS (∆VirB2-VirB11) supports bacterial
replication in the zebrafish embryos although to a lesser extent than the WT bacteria.
These data suggest that the VirB machinery and even its cognate effectors are not an
absolute requirement for establishing an infection in the zebrafish embryo model.
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However, an abrogated response to infection with the ΔvirB mutant is observed in the
embryos; this further indicates that although the VirB T4SS is not absolutely required for
Bh survival in the zebrafish embryo, it may play a role in the pathogenicity of Bh in vivo.
The genome of Bh contains at least two forms of BadA-encoding genes: the fulllength version (BH01510), which was the gene deleted in the mutant used in this study,
and a truncated version (BH01490). It has been reported that some Bh isolates do not
express a functional BadA, and due to passaging histories, defined Bh strains may
exhibit distinct characteristics and infection phenotypes [264]. However, our Bh
Houston-1 strain was early passage and displayed a rough phenotype which correlates
with the presence of full-length BadA protein which was further confirmed by reactivity
with antibody specific for BadA (data not shown). While a deletion mutant for the major
trimeric autotransporter adhesin BadA appears to increase in fluorescence intensity
within the embryos over time, qPCR data indicated that this mutant was unable to
replicate and remained at a relatively constant bacterial burden as determined by the
GE/embryo. It has been reported that full-length BadA is essential for Bh adhesion to
host cells and extracellular matrix proteins leading to a direct angiogenic response by
stimulating HIF-1α production and VEGF secretion [76-78]. Therefore, we hypothesized
that, in absence of full-length BadA, Bh’s ability to adhere to target cells, establish
infection and initiate the induction of an angiogenic response would be hampered. Our
data showed that the Bh mutant for full-length BadA exhibited an abrogated angiogenic
response in the zebrafish embryo compared to WT although it may be possible that the
diminished ability of this mutant to replicate in the zebrafish embryos precluded the
establishment of a pro-angiogenic host response. Thus, our in vivo data support a major
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role for BadA in establishing infection and also possibly inducing a pro-angiogenic host
response. Although the function of the truncated version of BadA (BH01490) in Bh has
not been fully investigated, a compensatory role in inducing an angiogenic phenotype
following the loss of full-length BadA can’t be eliminated in the ΔbadA mutant.
In conclusion, we have developed an animal model to study Bh infection and
pathogenesis. We demonstrated that zebrafish embryos microinjected in the yolk sac
became infected with Bh and exhibited evidence of an angiogenic response as well as
an inflammatory response involving recruitment and accumulation of neutrophils and
macrophages to the site of infection. We found that the Bh mutants for virB T4SS and
the full-length BadA induced abrogated pro-inflammatory and pro-angiogenic responses
when compared to the WT in the zebrafish embryo. Moreover, we also found that the
full-length BadA mutant showed a limited ability to replicate when compared to the WT
suggesting that this in vivo model is a useful system in which to assess virulence. The
infection pattern with Bh was not assessed beyond day 8 post-inoculation as embryos
are capable of obtaining nutrition from the yolk sac during this time period and extension
of the period of infection would require supplemental food sources – possibly
introducing microbial contaminants. Regardless, we believe that the use of zebrafish
embryos as a model of Bh infection proved highly successful and provided valuable
insight which can only be gathered from an in vivo model system.
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Chapter 5
Future Studies
Although the Bh mutant for full-length BadA exhibited an abrogated response in
the zebrafish embryo, because a compensatory role of the short version of BadA
following the loss of full-length BadA may be at play in the ΔbadA mutant, future studies
should focus on making a double knock out of both the full-length and the truncated
versions of BadA and study their roles in Bh infection. It has been assumed that BadA
and the VirB/D4 T4SS may act synergistically in that the BadA-induced adhesion to host
cells brings the bacteria and the host cells into close proximity facilitating the secretion
of the effector proteins by the VirB/D4 T4SS [64]. Although the synergistic effect of
those two important virulence factors in Bh has not been elucidated in vitro, it would be
interesting to investigate the effect of a double knock out mutant of those genes on Bh
pathogenesis in the zebrafish embryo. Moreover, studies complementing the genes into
the respective knock out strains will be important in confirming that the phenotypic and
or genotypic effects are due to the respective genes.
Bh infection induced migration of phagocytic cells to the site of infection.
Interestingly, although the phagocytic cells were recruited to the infection site, the
majority of the bacteria were not phagocytized. The role of those phagocytes in
clearance of the bacteria remains to be determined. The myeloid cells can be depleted
in the zebrafish embryos using morpholino knockdown of the myeloid transcription
factor Pu.1, which has been shown to be required for myelopoiesis in zebrafish [212].
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The infection pattern and the response to infection with Bh could then be studied in the
macrophage- and neutrophil-depleted embryos. Moreover, since there is a dramatic
decrease in bacterial burden starting at day 4 or 5 post infection, there may be a
respiratory burst killing of the bacteria by the zebrafish embryo immune system. The
production of reactive nitrogen and reactive oxygen species is an important effector
mechanism of the innate immunity in response to infection of the zebrafish embryo. The
role of respiratory burst killing in clearance of the bacteria by the embryos can be
assessed by an assay measuring the oxidation of 2′,7′-dihydrodichlorofluorescein
diacetate

(H2DCFDA),

a

non-fluorescent

dichlorofluorescein (DCF) [265].
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